Endocrine, nutritional and metabolic diseases

E4_ENDONUTRMET

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E00-E90 Hospital discharge: ICD-9 — 2[4-7] Hospital discharge: ICD-8 — 2[4-7] Cause of death: ICD-10 — E00-E90 Cause of death: ICD-9 — 2[4-7] Cause of death: ICD-8 — 2[4-7] 2 out of 7 registries used, show all original rules.	174048
4. Check minimum number of events None	174048
5. Include endpoints E4_THYROID E4_DIABETES E4_GLUCOPANCREAS E4_ENDOGLAND E4_MALNUTRITION E4_NUTRIDEF E4_OBESITY E4_METABOLIA	219038
6. Filter based on genotype QC (FinnGen only)	219038

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 1
First used in FinnGen datafreeze: DF10

NAME	E4_ENDONUTRMET
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_THYROID\|E4_DIABETES\|E4_GLUCOPANCREAS\|E4_ENDOGLAND\|E4_MALNUTRITION\|E4_NUTRIDEF\|E4_OBESITY\|E4_METABOLIA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E
HD_ICD_9	2[4-7]
HD_ICD_8	2[4-7]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E
COD_ICD_9	2[4-7]
COD_ICD_8	2[4-7]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Endocrine, nutritional and metabolic diseases based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	219038	126477	92561
Unadjusted period prevalence (%)	42.14	43.11	40.81
Median age at first event (years)	55.02	51.87	59.34

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3773: Matched controls
23408

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

8086.0

323.0

978

SPAT1262

SPAT

Handing over of treatment supplies

31.3

323.0

729

178

103

Kela drug reimbursment

Diabetes, insulin-treated

+∞

323.0

1146

215

Kela drug reimbursment

Diabetes, non-insulin-treated

+∞

323.0

1131

A10AE04

ATC

insulin glargine; parenteral

5593.1

323.0

736

H03AA01

ATC

levothyroxine sodium; systemic

60.7

323.0

735

E66.01

ICD-10 Finland

Obesity due to excess calories

40.9

323.0

524

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2138.3

323.0

598

T89

ICPC

Diabetes insulin dependent

5274.0

323.0

702

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

+∞

323.0

410

A10AE05

ATC

insulin detemir; parenteral

4022.4

323.0

561

A10AE06

ATC

insulin degludec; parenteral

+∞

323.0

439

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

+∞

323.0

391

E10

ICD-10 Finland

Type 1 diabetes mellitus

2559.6

323.0

379

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1564.7

323.0

653

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

+∞

323.0

564

H04AA01

ATC

glucagon; nasal, parenteral

+∞

323.0

733

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3413.4

323.0

869

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

13.2

294.5

608

335

A10BA02

ATC

metformin; oral

121.0

291.1

370

XCK10

NOMESCO Finland

Photography of fundus of eye

23.1

275.1

463

141

T90

ICPC

Diabetes non-insulin dependent

76.6

261.0

348

A10AA01

ATC

+∞

237.0

272

A10AA02

ATC

+∞

236.1

271

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

230.8

265

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

122.1

201.6

257

Z01.0

ICD-10 Finland

Examination of eyes and vision

4.8

201.0

821

1270

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

+∞

197.3

227

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

43.7

189.5

275

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

1279.4

173.0

202

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

167.4

193

E66.8

ICD-10 Finland

Other obesity

73.6

158.6

213

177

Kela drug reimbursment

Insulin glargine 300 U / ml

+∞

157.7

182

H3600, E103

ICD-10 Finland

+∞

152.5

176

C10AA05

ATC

atorvastatin; oral

13.1

145.9

299

153

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

1111.9

142.4

167

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

14.8

140.8

274

123

E66.9

ICD-10 Finland

Obesity, unspecified

35.5

133.2

201

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

+∞

132.4

153

C10AA07

ATC

rosuvastatin; oral

18.1

127.9

231

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

8.6

126.3

319

248

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

+∞

120.2

139

E34.35

ICD-10 Finland

Abnormal growth retardation

+∞

119.3

138

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

26.9

118.2

190

H3601, E103

ICD-10 Finland

+∞

114.9

133

CKC12

NOMESCO Finland

Photocoagulation of retina

28.0

113.8

181

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

14.1

113.3

224

104

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

430.1

112.0

134

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

106.2

123

E66.00

ICD-10 Finland

Metabolic syndrome

30.8

104.2

162

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

5.5

102.4

356

437

I10

ICD-10 Finland

Essential (primary) hypertension

5.1

100.2

371

490

101

Kela drug reimbursment

Anterior pituitary hypofunction

+∞

100.1

116

104

Kela drug reimbursment

Thyroid insufficiency

+∞

97.5

113

H3603, E103

ICD-10 Finland

+∞

91.5

106

C10AA01

ATC

simvastatin; oral

15.0

91.4

176

RD210

NOMESCO Finland

14.0

90.5

179

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

94.4

90.3

118

H03BB01

ATC

carbimazole; oral

656.2

86.9

103

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

+∞

86.2

100

E11

ICD-10 Finland

Type 2 diabetes mellitus

43.8

85.0

123

H36.00

ICD-10 Finland

Diabetic background retinopathy

+∞

84.5

T86

ICPC

Hypothyroidism/myxoedema

57.6

84.4

117

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

7.7

83.3

223

189

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

311.1

80.9

C09AA05

ATC

ramipril; oral

9.5

79.3

188

129

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

45.2

78.5

113

G47.3

ICD-10 Finland

Sleep apnoea

3.6

78.4

419

784

H01AC01

ATC

somatropin; parenteral

298.0

77.5

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

33.7

76.3

116

E03

ICD-10 Finland

Other hypothyroidism

36.1

75.3

113

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

+∞

75.0

H36.01

ICD-10 Finland

Diabetic maculopathy

551.7

73.1

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

8.4

69.4

176

136

E30.09

ICD-10 Finland

Delayed puberty NOS

262.2

68.1

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

+∞

68.1

E03.89

ICD-10 Finland

Other specified hypothyroidism

64.2

66.7

TBW99

NOMESCO Finland

Other minor procedure in endocrine surgery

53.2

65.7

WZC30

NOMESCO Finland

Teaching

4.0

64.9

305

508

C09AA02

ATC

enalapril; systemic

7.7

64.7

172

144

A10BK03

ATC

empagliflozin; oral

+∞

62.9

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

75.2

62.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

61.6

822

2659

E66

ICD-10 Finland

Obesity

6.9

60.5

173

162

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

454.6

60.2

T82

ICPC

Obesity

7.3

58.9

162

143

A10BK01

ATC

dapagliflozin; oral

226.5

58.7

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

58.1

735

2310

R4190

NOMESCO Finland

Nutritional therapy

5.5

57.4

195

230

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

428.8

56.8

C07AB07

ATC

bisoprolol; oral

2.9

56.3

403

925

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

216.8

56.1

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

55.9

483

1244

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

39.9

55.9

E86

ICD-10 Finland

Volume depletion

78.0

55.6

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

4.4

55.6

233

347

C08CA01

ATC

amlodipine; oral

4.9

55.2

208

277

A10AB06

ATC

insulin glulisine; parenteral

+∞

55.1

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

+∞

55.1

E30.00

ICD-10 Finland

Familial delayed puberty

145.3

54.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.2

52.1

320

660

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.5

52.0

279

518

A10AA03

ATC

+∞

51.6

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

26.0

51.0

A10AD04

ATC

insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

+∞

49.9

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

5.1

49.7

180

229

E66.0

ICD-10 Finland

Obesity due to excess calories

100.9

49.4

BAA60

NOMESCO Finland

Total thyroidectomy

97.7

47.7

E29.1

ICD-10 Finland

Testicular hypofunction

19.5

47.6

C09CA01

ATC

losartan; oral

5.4

46.8

161

193

N05AH04

ATC

quetiapine; oral

2.0

46.6

725

2463

E30.1

ICD-10 Finland

Precocious puberty

+∞

46.4

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.6

45.6

400

1033

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.4

45.3

456

1271

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.6

44.4

226

402

H02AB09

ATC

hydrocortisone; systemic

5.9

44.0

140

152

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

26.0

43.6

E34.30

ICD-10 Finland

Short stature NOS

170.3

43.4

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

42.8

735

2586

A02BC02

ATC

pantoprazole; systemic

1.8

42.1

1067

4288

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

+∞

42.1

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

41.9

417

1152

R5140

NOMESCO Finland

Monitoring the use of the aid

4.5

41.6

168

241

H43.1

ICD-10 Finland

Vitreous haemorrhage

24.9

41.3

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

41.3

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

4.3

41.2

174

261

127

Kela drug reimbursment

Transplant complication

9.8

40.9

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

40.5

274

603

J01DB01

ATC

cefalexin; oral

1.7

40.4

2683

14001

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

40.1

519

1623

121

Kela drug reimbursment

Severe hypofunction of sexual glands

19.2

40.1

C10AX09

ATC

ezetimibe; oral

29.6

39.3

C03CA01

ATC

furosemide; systemic

5.6

39.1

129

147

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

39.0

1215

5168

R11

ICD-10 Finland

Nausea and vomiting

2.7

38.8

303

730

A10BH01

ATC

sitagliptin; oral

+∞

38.7

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

38.6

712

2563

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

5.5

38.4

128

148

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

+∞

37.8

TPH07

NOMESCO Finland

Cathetrisation of artery

3.9

37.7

176

290

E87.6

ICD-10 Finland

Hypokalaemia

147.6

37.5

N02BE01

ATC

paracetamol; systemic, rectal

1.6

37.4

2180

10873

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

37.0

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

36.1

ZXA10

NOMESCO Finland

Bilateral

2.2

36.0

413

1221

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

268.8

35.4

H3602, E103

ICD-10 Finland

+∞

35.2

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

34.8

611

2151

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.5

34.4

184

341

N06AX11

ATC

mirtazapine; oral

1.8

33.9

688

2544

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

27.8

33.7

XF600

NOMESCO Finland

Bloodpressure measurement

3.0

33.7

218

464

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

+∞

33.5

N05BA04

ATC

oxazepam; oral

2.0

32.9

478

1563

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

67.4

32.0

A10BJ06

ATC

semaglutide; parenteral

+∞

31.8

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

31.8

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.7

31.6

154

264

R50.9

ICD-10 Finland

Fever, unspecified

1.9

31.3

530

1835

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

31.2

426

1355

205

Kela drug reimbursment

Chronic hypertension

6.1

31.2

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

65.8

31.1

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

40.3

31.0

N02AX02

ATC

tramadol; systemic, rectal

1.9

31.0

565

2009

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

30.9

1008

4285

A11CC03

ATC

alfacalcidol; systemic

11.1

30.3

N05AX08

ATC

risperidone; systemic

2.4

30.3

292

789

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

230.7

30.3

E27.0

ICD-10 Finland

Other adrenocortical overactivity

+∞

30.1

E34.40

ICD-10 Finland

Constitutional tall stature

+∞

30.1

171

Kela drug reimbursment

Degludekinsuliini

+∞

30.1

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

+∞

30.1

N06AB10

ATC

escitalopram; oral

1.7

30.1

717

2783

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

29.7

306

856

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

29.4

428

1398

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

13.8

29.3

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

29.3

427

1395

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

+∞

29.2

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

9.6

29.2

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

10.4

28.6

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

+∞

28.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

28.2

522

1862

XCD10

NOMESCO Finland

Electrophysiological examination of eye

7.4

28.1

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

27.6

28.1

A02BC01

ATC

omeprazole; systemic

2.2

27.9

336

1011

E22.1

ICD-10 Finland

Hyperprolactinaemia

36.7

27.8

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

+∞

27.5

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

27.3

490

1728

N06AB03

ATC

fluoxetine; oral

2.2

27.2

305

888

N06AX16

ATC

venlafaxine; oral

2.0

27.1

386

1247

OAB50

SPAT

47.6

27.0

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.3

26.9

108

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

5.5

26.8

103

R53

ICD-10 Finland

Malaise and fatigue

1.9

26.7

476

1672

Z96.4

ICD-10 Finland

Presence of endocrine implants

+∞

26.6

N05AX12

ATC

aripiprazole; systemic

2.3

26.6

289

829

N03AX16

ATC

pregabalin; oral

2.2

26.2

289

834

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.6

26.0

220

554

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.9

25.9

C07AA05

ATC

propranolol; systemic

1.8

25.8

515

1881

E14.1

ICD-10 Finland

Unspecified diabetes mellitus, with ketoacidosis

+∞

25.8

E34.45

ICD-10 Finland

Abnormal growth increase

+∞

25.8

E16.19

ICD-10 Finland

Other specified hypoglycaemia

+∞

25.8

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

25.7

25.8

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.3

25.7

267

747

A46

ICD-10 Finland

Erysipelas

2.8

24.9

183

423

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

+∞

24.9

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

3.6

24.8

125

221

TK800

NOMESCO Finland

Hemodialysis

8.1

24.8

R4110

NOMESCO Finland

Physiotherapy

1.8

24.8

495

1808

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.8

24.6

114

188

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

12.1

24.4

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

24.4

294

882

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

15.7

24.4

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.3

24.4

265

758

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

188.5

24.3

SPAT1054

SPAT

Examination of peripheral nervous system

188.5

24.3

E22.80

ICD-10 Finland

Central precocious puberty

+∞

24.0

602

Kela drug reimbursment

Children's severe malnutrition

6.5

23.8

N06AB06

ATC

sertraline; oral

1.9

23.7

382

1291

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

23.7

562

2163

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

93.8

23.2

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

23.2

320

1019

J02AC01

ATC

fluconazole; systemic

1.9

23.2

378

1285

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

23.1

226

615

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.6

23.1

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

23.1

214

567

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.0

22.9

312

987

J01FF01

ATC

clindamycin; systemic

1.7

22.9

529

2019

C09CA06

ATC

candesartan; oral

2.5

22.7

198

508

301

Kela drug reimbursment

Growth hormone

175.5

22.6

SGA01

NOMESCO Finland

Tooth opening as first aid

1.7

22.4

532

2045

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

+∞

22.3

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

7.8

22.3

WX892

NOMESCO Finland

Monitored bed care

2.8

22.2

158

359

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

34.4

22.2

SPAT1263

SPAT

Sampling

1.4

22.1

1391

6744

XCH00

NOMESCO Finland

Eye pressure measurement

5.9

22.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

22.1

288

895

N05AH03

ATC

olanzapine; systemic

2.0

22.1

316

1021

Z71.8

ICD-10 Finland

Other specified counselling

1.6

22.0

772

3296

L04AA06

ATC

mycophenolic acid; systemic

5.6

22.0

F83

ICD-10 Finland

Mixed specific developmental disorders

3.4

22.0

120

226

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

3.6

22.0

110

194

N18.8

ICD-10 Finland

Other chronic renal failure

8.5

21.9

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.7

21.8

583

2319

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.3

21.8

123

239

N03AG01

ATC

valproic acid; systemic, rectal

2.4

21.8

207

555

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

4.0

21.7

149

Z94.0

ICD-10 Finland

Kidney transplant status

7.9

21.6

F93.89

ICD-10 Finland

Other childhood emotional disorders

2.9

21.6

148

329

E23.02

ICD-10 Finland

Neurosecretory dysfunction of the growth hormone

+∞

21.5

CL2S4

SPAT

+∞

21.5

A28

ICPC

Limited function/disability NOS

3.8

21.4

101

170

WX002

NOMESCO Finland

Sedation and analgesia

2.0

21.2

291

922

N06AX12

ATC

bupropion; oral

2.0

21.1

293

934

SPAT1229

SPAT

Assessment of need for aid

4.8

21.1

103

ZX120

NOMESCO Finland

Intravenous

2.5

21.0

182

466

SPAT1281

SPAT

Other administrative function

2.1

21.0

261

795

Z45.1

ICD-10 Finland

Adjustment and management of infusion pump

+∞

20.6

E10.09

ICD-10 Finland

Insulin-dependent diabetes mellitus - With coma

+∞

20.6

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

+∞

20.6

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

3.4

20.6

110

205

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

45.3

20.5

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

20.5

133

285

XA800

NOMESCO Finland

Neuropsychological investigation

3.0

20.4

131

278

R03AC02

ATC

salbutamol; inhalant

1.4

20.2

1504

7490

WX110

NOMESCO Finland

Local anesthesy

1.4

20.2

2507

13676

ZXA00

NOMESCO Finland

Right side

1.8

20.1

375

1334

N02AA05

ATC

oxycodone; systemic

3.4

20.1

106

196

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

20.1

1571

7893

K90.0

ICD-10 Finland

Coeliac disease

3.5

20.0

104

190

Z31.5

ICD-10 Finland

Genetic counselling

2.6

19.8

162

399

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

11.9

19.6

SPAT1310

SPAT

Counselling related to known health issue

1.4

19.5

1126

5338

N03AX12

ATC

gabapentin; oral

2.3

19.5

190

517

ZXA05

NOMESCO Finland

Left side

1.8

19.5

349

1223

WX402

NOMESCO Finland

General anaesthesia

1.8

19.4

381

1379

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

19.3

194

535

S18

ICPC

Laceration/cut

1.5

19.2

957

4402

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

3.2

19.2

113

227

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

78.0

19.0

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

3.1

19.0

115

235

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

19.0

382

1393

N04BC06

ATC

cabergoline; oral (dopamine agonists)

+∞

18.9

N03AX09

ATC

lamotrigine; oral

2.4

18.7

180

487

N06AB04

ATC

citalopram; systemic

2.0

18.7

280

921

137

Kela drug reimbursment

Uraemia requiring dialysis

14.6

18.7

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

14.6

18.7

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

8.0

18.4

CK2S4

SPAT

143.5

18.4

Z51.80

ICD-10 Finland

Manipulation of puberty development with hormone therapy

143.5

18.4

TQB05

NOMESCO Finland

Puncture of skin of trunk

15.2

18.4

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

18.3

415

1568

B03XA02

ATC

darbepoetin alfa; parenteral

11.3

18.3

E73.9

ICD-10 Finland

Lactose intolerance, unspecified

8.7

18.1

A10BD07

ATC

metformin and sitagliptin; systemic

+∞

18.0

E30.9

ICD-10 Finland

Disorder of puberty, unspecified

+∞

18.0

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

18.0

1555

7898

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.4

17.9

102

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

22.6

17.8

B05DA

ATC

Isotonic solutions

17.6

17.7

E80.4

ICD-10 Finland

Gilbert syndrome

25.0

17.7

M79.6

ICD-10 Finland

Pain in limb

1.5

17.5

706

3096

WW200

NOMESCO Finland

Immunization

3.2

17.2

100

198

T99

ICPC

Endocr/metab/nutrit disease other

13.8

17.2

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.7

17.2

126

293

WX780

NOMESCO Finland

Remote monitoring CPAP

4.2

17.2

109

A12AA04

ATC

calcium carbonate; oral

10.5

17.2

CL2L4

NOMESCO Finland

Wide-field fundus photography for diabetic retinopathy screening

+∞

17.2

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

9.4

17.1

WX882

NOMESCO Finland

High dependency care

3.3

17.0

176

N05CF01

ATC

zopiclone; oral

1.9

17.0

297

1031

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.9

16.9

112

244

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

16.9

534

2210

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

16.8

1812

9501

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

130.9

16.7

C07AB02

ATC

metoprolol; systemic

3.2

16.7

183

N06AX21

ATC

duloxetine; oral

2.3

16.7

176

496

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

16.7

1067

5126

JN4BD

NOMESCO Finland

Extensive body CT

2.9

16.6

111

244

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.9

16.6

274

933

OAB72

NOMESCO Finland

Weight control and weight loss guidance

19.4

16.5

J01AA02

ATC

doxycycline; systemic

1.4

16.5

1158

5652

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

16.5

152

402

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

16.4

415

1619

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

16.4

547

2291

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

+∞

16.3

E34.31

ICD-10 Finland

Short stature, prenatal disorder

+∞

16.3

RS221

NOMESCO Finland

5.3

16.3

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.5

16.2

144

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

16.5

16.2

WW500

NOMESCO Finland

Blood transfusion

4.8

16.2

L04AD01

ATC

ciclosporin; systemic

4.1

16.0

105

A06AD11

ATC

lactulose; oral

2.2

16.0

176

509

R2110

NOMESCO Finland

Giving the first information

3.2

15.9

180

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

8.9

15.9

V03AE01

ATC

polystyrene sulfonate; oral

12.9

15.9

C03DA01

ATC

spironolactone; oral

4.0

15.8

109

E06.3

ICD-10 Finland

Autoimmune thyroiditis

29.9

15.8

R4180

NOMESCO Finland

Podiatric therapy

18.7

15.8

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

15.8

587

2523

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

65.5

15.7

T45

ICPC

Metabolic, Observ/health educat/advice/diet

65.5

15.7

186

Kela drug reimbursment

Growth retardation associated with renal failure (growth hormone)

65.5

15.7

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

3.0

15.7

101

216

WX723

NOMESCO Finland

CPAP therapy

4.1

15.7

101

N01BB20

ATC

amides - combinations; parenteral

3.2

15.6

172

SPAT1377

SPAT

Polysomnography

3.7

15.6

123

B01AB05

ATC

enoxaparin; parenteral

2.0

15.6

217

693

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

15.6

1399

7098

R51.80

ICD-10 Finland

Headache

1.6

15.5

488

2014

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

5.0

15.5

E23.2

ICD-10 Finland

Diabetes insipidus

+∞

15.5

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

+∞

15.5

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.1

15.4

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.2

15.2

175

515

S97

ICPC

Chronic ulcer skin

4.0

15.2

101

N05AH02

ATC

clozapine; systemic

2.6

15.2

123

305

SPAT1139

SPAT

Nutrition survey

3.0

15.1

193

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

15.1

185

561

211

Kela drug reimbursment

Severe hereditary disorders of lipid metabolism (familial hypercholesterolaemia and type III dyslipoproteinemia)

118.4

15.1

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

28.7

15.1

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

28.7

15.1

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

28.7

15.1

G03FB08

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

62.4

14.9

196

Kela drug reimbursment

Paricalcitol and cinacalcet

43.7

14.9

L28

ICPC

Limited function/disability (L)

2.2

14.9

161

461

C08CA13

ATC

lercanidipine; oral

7.2

14.8

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.3

14.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

14.6

885

4190

Z49.1

ICD-10 Finland

Extracorporeal dialysis

9.4

14.6

A10BJ02

ATC

liraglutide; parenteral

+∞

14.6

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

+∞

14.6

H05BX01

ATC

cinacalcet; oral

+∞

14.6

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

+∞

14.6

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

16.2

14.5

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

14.4

139

377

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

14.4

330

1249

A05AA02

ATC

ursodeoxycholic acid; oral

4.5

14.4

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

14.3

243

836

XF602

NOMESCO Finland

Bloodpressure monitoring

6.6

14.3

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

17.3

14.3

XCD20

NOMESCO Finland

Photoangiography of eye

17.3

14.3

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

14.3

511

2173

XW000

NOMESCO Finland

Bone marrow biopsy

3.5

14.2

124

E30.8

ICD-10 Finland

Other disorders of puberty

32.7

14.2

ZX114

NOMESCO Finland

Intramuscular

5.9

14.1

H02AA02

ATC

fludrocortisone; oral

59.2

14.1

CKC15

NOMESCO Finland

Panretinal photocoagulation

41.6

14.1

RS220

NOMESCO Finland

4.6

14.1

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

14.0

435

1786

A09AA02

ATC

multienzymes (lipase, protease etc.)

10.4

14.0

K02.1

ICD-10 Finland

Caries of dentine

1.3

14.0

2281

12570

J01DA01

ATC

[U] cefalexin; systemic

1.3

14.0

1618

8488

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.8

13.9

284

1037

P01AB01

ATC

metronidazole; oral, rectal

1.5

13.9

496

2107

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.5

13.9

114

284

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.9

13.9

208

685

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.2

13.8

J01CA04

ATC

amoxicillin; systemic

1.5

13.8

3327

19514

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

11.7

13.8

WX140

NOMESCO Finland

Parabulbar anesthesy

7.5

13.7

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

+∞

13.7

102

Kela drug reimbursment

Diabetes insipidus

+∞

13.7

T69

ICPC

Metabolic, Other reason for encounter NEC

+∞

13.7

H3603, E113

ICD-10 Finland

+∞

13.7

RD120

NOMESCO Finland

+∞

13.7

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

+∞

13.7

E21.0

ICD-10 Finland

Primary hyperparathyroidism

+∞

13.7

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

13.7

1931

10410

M54.5

ICD-10 Finland

Low back pain

1.4

13.7

695

3181

SPAT1359

SPAT

Use of symptom diary

3.6

13.6

112

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.2

13.6

152

C08CA02

ATC

felodipine; oral

5.7

13.6

C02AC05

ATC

moxonidine; oral

12.0

13.5

C10AA03

ATC

pravastatin; oral

12.0

13.5

N05BA06

ATC

lorazepam; systemic, sublingual

3.2

13.5

153

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

13.5

199

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.7

13.5

291

1082

AA1AD

NOMESCO Finland

CT of head and brain

1.7

13.4

286

1059

A02BC05

ATC

esomeprazole; systemic

1.5

13.4

457

1920

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

105.9

13.4

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

105.9

13.4

L04AA01

ATC

[U] ciclosporin; systemic

7.9

13.4

L60.0

ICD-10 Finland

Ingrowing nail

2.0

13.3

180

569

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

13.3

1825

9786

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.1

13.2

155

462

K04.0

ICD-10 Finland

Pulpitis

1.6

13.2

336

1310

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

13.2

320

1232

M41.4

ICD-10 Finland

Neuromuscular scoliosis

19.6

13.1

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.6

13.1

101

244

XCK00

NOMESCO Finland

Perimetry

3.0

13.0

174

B05DB

ATC

Hypertonic solutions

13.0

12.9

RD112

NOMESCO Finland

21.8

12.9

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.2

12.9

139

399

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

12.9

421

1749

105

Kela drug reimbursment

Adrenal cortical hypofunction

+∞

12.9

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

+∞

12.9

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

+∞

12.9

E06.1

ICD-10 Finland

Subacute thyroiditis

+∞

12.9

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.5

12.8

I50.9

ICD-10 Finland

Heart failure, unspecified

7.7

12.8

C07AG02

ATC

carvedilol; oral

8.1

12.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

12.7

191

629

L02AE02

ATC

leuprorelin; implant, parenteral

13.6

12.7

H26.2

ICD-10 Finland

Complicated cataract

13.6

12.7

SPAT1301

SPAT

No procedures

1.4

12.7

913

4439

UJD02

NOMESCO Finland

Gastroscopy

3.2

12.6

140

SPAT1097

SPAT

Recording of ECG

2.1

12.6

158

484

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

12.6

502

2183

N06BA04

ATC

methylphenidate; oral

1.8

12.6

223

780

E23.05

ICD-10 Finland

Lack of TSH

99.6

12.6

E87.5

ICD-10 Finland

Hyperkalaemia

99.6

12.6

T48

ICPC

Metabolic, Clarification/discussion RFE/demand

99.6

12.6

R42

ICD-10 Finland

Dizziness and giddiness

1.7

12.5

265

980

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

12.5

127

355

N03AX11

ATC

topiramate; oral

3.2

12.5

134

SPAT1252

SPAT

Overall medication plan or its review

3.2

12.5

134

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

12.5

193

644

R62.8

ICD-10 Finland

Other lack of expected normal physiological development

4.0

12.5

SPAT1283

SPAT

Restricted health certificate

1.3

12.4

985

4859

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

12.4

489

2120

T31

ICPC

Metabolic, Medical examin/health eval partial

14.3

12.4

T87

ICPC

Hypoglycaemia

18.7

12.4

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

12.4

155

476

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

12.4

378

1547

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

12.3

152

464

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

11.1

12.2

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.8

12.1

WX290

NOMESCO Finland

Other blockade of nerve

1.3

12.1

1885

10224

J01MA12

ATC

levofloxacin; systemic

1.9

12.1

178

582

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

12.0

204

702

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

+∞

12.0

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

+∞

12.0

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

+∞

12.0

A10BX01

ATC

guar gum; systemic

+∞

12.0

Z49.2

ICD-10 Finland

Other dialysis

13.0

12.0

P06

ICPC

Sleep disturbance

1.6

11.9

315

1243

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.3

11.8

L84

ICD-10 Finland

Corns and callosities

3.9

11.8

F59

ICD-10 Finland

Unspecified behavioural syndromes associated with physiological disturbances and physical factors

10.4

11.8

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

11.8

206

SGB20

NOMESCO Finland

Filling of root of tooth with 2 root channels

1.9

11.8

174

571

E03.1

ICD-10 Finland

Congenital hypothyroidism without goitre

93.4

11.7

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

4.2

11.7

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

17.8

11.6

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

11.6

348

1417

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

11.6

231

839

T07

ICPC

Weight gain

3.1

11.6

132

F43.8

ICD-10 Finland

Other reactions to severe stress

2.7

11.6

195

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

11.5

110

299

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.6

11.5

208

B03BA03

ATC

hydroxocobalamin; parenteral

9.7

11.4

K85

ICPC

Elevated blood pressure

2.7

11.4

194

UDC00

NOMESCO Finland

Ear microscopy

1.7

11.4

236

869

J01MA02

ATC

ciprofloxacin; systemic

1.5

11.3

466

2038

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.3

11.3

113

313

E73.8

ICD-10 Finland

Other lactose intolerance

12.5

11.3

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

11.3

108

293

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

5.4

11.2

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.7

11.2

192

R5599

NOMESCO Finland

Other rehabilitation service

2.8

11.2

171

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

+∞

11.2

T30

ICPC

Metabolic, Medical examin/health eval complete

+∞

11.2

2680A

ICD-9 Finland

Vitamin D deficiency, Rickets, active

+∞

11.2

QBJ30

NOMESCO Finland

Correction of abdominal apron

+∞

11.2

T89

ICD-10 Finland

+∞

11.2

P85

ICPC

Mental retardation

8.0

11.1

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

11.1

130

387

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.3

11.1

109

G03GA01

ATC

chorionic gonadotrophin; parenteral

4.3

11.1

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

26.5

11.1

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

11.0

1993

10966

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

10.9

181

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

1.6

10.9

273

1059

C09BA02

ATC

enalapril and diuretics; systemic

16.9

10.9

SPAT1240

SPAT

Therapeutic discussion

1.4

10.9

506

2269

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.7

10.9

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

46.7

10.9

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

46.7

10.9

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.6

10.9

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

10.8

269

1041

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

10.8

185

640

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

3.3

10.8

108

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

8.7

10.8

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

10.8

219

801

SPAT1260

SPAT

Consultation of another employee

1.5

10.7

421

1823

L17

ICPC

Foot/toe symptom/complaint

1.4

10.7

697

3318

V03AE02

ATC

sevelamer; oral

18.7

10.7

C09CA03

ATC

valsartan; oral

6.0

10.7

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

10.6

101

275

A02BA02

ATC

ranitidine; systemic

2.3

10.5

103

282

CKD40

NOMESCO Finland

Endophotocoagulation of retina

10.6

10.5

F43

ICPC

Eye, Other diagnostic procedure

8.2

10.5

N18.0

ICD-10 Finland

End-stage renal disease

8.8

10.5

CKC10

NOMESCO Finland

Local photocoagulation of retina

14.8

10.5

SPAT1100

SPAT

Long-term monitoring of blood pressure

4.0

10.4

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

10.4

359

1509

SPAT1255

SPAT

Intravenous administration of medicine

2.6

10.4

187

TAB00

NOMESCO Finland

Lumbar puncture

2.2

10.4

107

302

N05AA02

ATC

levomepromazine; systemic

2.6

10.4

193

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.7

10.4

N03AE01

ATC

clonazepam; systemic

2.5

10.4

222

N05BA01

ATC

diazepam; systemic, rectal

1.7

10.3

221

821

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

12.5

10.3

K04.08

ICD-10 Finland

Other specified pulpit

1.7

10.3

237

898

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

4.2

10.3

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

+∞

10.3

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

+∞

10.3

371

Kela drug reimbursment

Degludekinsuliini

+∞

10.3

E83.39

ICD-10 Finland

Other disorder of phosphorus metabolism

+∞

10.3

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

10.2

249

959

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

10.2

354

1491

L03AA02

ATC

filgrastim; parenteral

4.4

10.2

E78.11

ICD-10 Finland

Other hypertriglyceridemia

31.1

10.1

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

10.1

149

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

10.1

201

728

R06.5

ICD-10 Finland

Mouth breathing

1.8

10.1

180

631

E83.51

ICD-10 Finland

Hypocalcemia

80.9

10.1

T83

ICPC

Overweight

2.9

10.0

132

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

10.0

152

504

J01FA10

ATC

azithromycin; systemic

1.3

10.0

2313

13034

S01ED51

ATC

timolol, combinations; ophthalmic

4.1

10.0

UJF32

NOMESCO Finland

Coloscopy

1.6

10.0

262

1032

N06AX26

ATC

vortioxetine; oral

1.7

10.0

224

843

P01

ICPC

Feeling anxious/nervous/tense

1.3

9.9

731

3546

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

9.9

268

0088X

ICD-9 Finland

Intestinal infections due to other organisms, Other organism, not elsewhere classified

2.8

9.9

155

R03BA02

ATC

budesonide; inhalant

1.4

9.9

449

2002

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

8.4

9.8

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.0

9.8

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

9.8

236

907

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

4.1

9.8

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.0

9.8

122

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.8

9.8

171

596

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

9.8

274

1097

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.0

9.8

127

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

9.8

2495

14206

201

Kela drug reimbursment

Chronic cardiac insufficiency

3.4

9.7

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

14.0

9.7

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

9.7

100

281

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

5.1

9.7

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.9

9.7

138

ZX112

NOMESCO Finland

Subcutaneous

4.2

9.7

C09CA07

ATC

telmisartan; oral

5.5

9.7

C09DA01

ATC

losartan and diuretics; oral

7.1

9.7

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

3.0

9.7

120

B03XA01

ATC

erythropoietin; parenteral

11.8

9.6

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

9.6

211

791

QDH05

NOMESCO Finland

Correction of deformity of toe nail

10.4

9.5

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

9.5

259

1029

R03BA05

ATC

fluticasone; inhalant

1.4

9.5

544

2529

N05AN01

ATC

lithium; oral

2.6

9.5

173

TK820

NOMESCO Finland

Peritoneal dialysis

15.1

9.5

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

15.1

9.5

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

9.5

147

M25.5

ICD-10 Finland

Pain in joint

1.4

9.5

538

2501

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.9

9.4

127

T66

ICPC

Metabolic, Referral to non-MD provider

+∞

9.4

QDH

NOMESCO Finland

Operations on toe nails

+∞

9.4

124

Kela drug reimbursment

Inborn metabolic disorders

+∞

9.4

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

+∞

9.4

Z50.1

ICD-10 Finland

Other physical therapy

2.7

9.4

158

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.6

9.4

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

9.4

167

586

N05AD01

ATC

haloperidol; systemic

3.1

9.4

110

RS140

NOMESCO Finland

4.0

9.4

E83.50

ICD-10 Finland

Hypercalcemia

29.0

9.4

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

12.5

9.3

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

9.3

127

404

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

9.3

123

388

R94.6

ICD-10 Finland

Abnormal results of thyroid function studies

7.5

9.3

XKD00

NOMESCO Finland

Uroflowmetry

2.0

9.3

119

371

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.4

9.2

203

N06BA09

ATC

atomoxetine; oral

3.9

9.2

XG466

NOMESCO Finland

Sleep oxymetry

4.1

9.2

JDB10

NOMESCO Finland

Percutaneous gastrostomy

9.6

9.2

SPAT1312

SPAT

General health counselling

1.3

9.2

1325

7035

XX3DW

NOMESCO Finland

Time consuming IT work

2.3

9.2

244

TKC20

NOMESCO Finland

Catheterisation of bladder

2.6

9.2

163

JN4AD

NOMESCO Finland

Body CT examination

3.1

9.1

105

R06AE07

ATC

cetirizine; oral

1.3

9.1

1420

7607

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

9.1

213

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

9.1

995

5100

R4140

NOMESCO Finland

Psychotherapy

3.4

9.1

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.8

9.1

134

RS224

NOMESCO Finland

4.2

9.1

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.7

9.0

145

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.8

9.0

130

R06.0

ICD-10 Finland

Dyspnoea

1.5

9.0

337

1442

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.0

9.0

127

410

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.4

9.0

203

N05CF02

ATC

zolpidem; oral

1.7

9.0

202

761

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

18.7

9.0

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

9.0

192

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.7

8.9

V03AG01

ATC

sodium cellulose phosphate; systemic

7.6

8.9

A03FA02

ATC

cisapride; oral, rectal

2.1

8.9

110

336

L02BG04

ATC

letrozole; oral

4.2

8.9

ZX090

NOMESCO Finland

Other technic of radiotherapy

8.2

8.9

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

2.6

8.9

164

M01AE02

ATC

naproxen; oral, rectal

1.2

8.9

1724

9461

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

8.9

799

3988

SPAT1365

SPAT

Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools

2.4

8.9

201

S10

ICPC

Boil/carbuncle

1.9

8.8

143

487

Z61.8

ICD-10 Finland

Other negative life events in childhood

3.7

8.8

D09

ICPC

Nausea

1.5

8.8

320

1362

D01

ICPC

Abdominal pain/cramps general

1.4

8.8

454

2072

L73.2

ICD-10 Finland

Hidradenitis suppurativa

3.8

8.8

F84.5

ICD-10 Finland

Asperger syndrome

2.2

8.8

251

L03.9

ICD-10 Finland

Cellulitis, unspecified

3.0

8.7

112

R4120

NOMESCO Finland

Occupational therapy

2.0

8.7

108

332

Z49.0

ICD-10 Finland

Preparatory care for dialysis

11.8

8.6

Z99.2

ICD-10 Finland

Dependence on renal dialysis

11.8

8.6

WX610

NOMESCO Finland

Patient controlled analgesia

7.7

8.6

N05AE04

ATC

ziprasidone; systemic

3.9

8.6

RJ411

NOMESCO Finland

27.0

8.6

J02AC04

ATC

posaconazole; systemic

27.0

8.6

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

27.0

8.6

C09AA04

ATC

perindopril; oral

10.2

8.6

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

+∞

8.6

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

+∞

8.6

J01GB01

ATC

tobramycin; inhalant, parenteral

+∞

8.6

E10.0

ICD-10 Finland

Type 1 diabetes mellitus, With coma

+∞

8.6

A10BG03

ATC

pioglitazone; oral

+∞

8.6

E23.03

ICD-10 Finland

Lack of ACTH

+∞

8.6

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

+∞

8.6

304

Kela drug reimbursment

Dornase alfa

+∞

8.6

503

Kela drug reimbursment

Inborn metabolic disorders

+∞

8.6

E55.0

ICD-10 Finland

Rickets, active

+∞

8.6

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

8.6

229

L05.0

ICD-10 Finland

Pilonidal cyst with abscess

2.3

8.6

209

M03BX02

ATC

tizanidine; oral

1.3

8.6

977

5029

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.5

8.6

172

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

8.5

263

1077

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

8.5

160

573

A08.0

ICD-10 Finland

Rotaviral enteritis

2.6

8.5

150

I15.8

ICD-10 Finland

Other secondary hypertension

15.6

8.5

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

8.5

283

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

8.5

650

3168

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.5

8.5

N04AA02

ATC

biperiden; systemic

3.4

8.5

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

8.5

425

1929

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

37.3

8.5

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

5.8

8.5

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.9

8.4

111

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.5

8.4

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

8.4

167

607

P76

ICPC

Depressive disorder

1.6

8.4

256

1047

E34.3

ICD-10 Finland

Short stature, not elsewhere classified

68.4

8.4

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

68.4

8.4

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

68.4

8.4

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

68.4

8.4

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

68.4

8.4

F50.9

ICD-10 Finland

Eating disorder, unspecified

2.3

8.4

207

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

8.4

141

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

8.4

104

319

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

6.9

8.4

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.2

8.4

235

P03

ICPC

Feeling depressed

1.4

8.4

517

2436

KGH10

NOMESCO Finland

Operation for phimosis

1.7

8.4

191

724

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.2

8.4

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

8.3

296

H02AB06

ATC

prednisolone; systemic

1.3

8.3

750

3739

SPAT1369

SPAT

Meeting with student welfare group of educational institution

2.7

8.3

133

WZC30

SPAT

3.9

8.3

N05BA09

ATC

clobazam; oral

3.5

8.3

B81

ICPC

Anaemia vit B12/folate deficiency

10.6

8.3

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

10.6

8.3

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

8.5

8.3

RK230

NOMESCO Finland

17.4

8.2

J04.0

ICD-10 Finland

Acute laryngitis

1.7

8.2

180

675

N07BA03

ATC

varenicline; oral

2.1

8.2

294

J01FA09

ATC

clarithromycin; systemic

1.3

8.2

808

4077

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

1.9

8.2

113

365

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

5.2

8.2

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.6

8.1

152

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

8.1

251

1030

Z00.8

ICD-10 Finland

Other general examinations

1.5

8.1

261

1080

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.0

8.1

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

8.1

100

309

RK260

NOMESCO Finland

13.3

8.1

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

8.0

259

1074

H02AB04

ATC

methylprednisolone; systemic

1.8

8.0

138

481

XX9XW

NOMESCO Finland

3.7

8.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

8.0

652

3204

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

20.2

8.0

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.5

8.0

260

1080

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

8.0

1434

7771

Z02.3

ICD-10 Finland

Examination for recruitment to armed forces

0.7

8.0

396

3238

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

8.0

209

822

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

4.1

8.0

F40.1

ICD-10 Finland

Social phobias

1.7

8.0

173

648

T28

ICPC

Limited function/disability (T)

11.1

8.0

TJD20

NOMESCO Finland

Change of gastrostomy tube

11.1

8.0

B01AB10

ATC

tinzaparin; parenteral

3.2

7.9

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

7.9

267

TK810

NOMESCO Finland

Hemofiltration

9.6

7.9

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.6

7.9

141

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.5

7.9

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

7.9

216

860

P99

ICPC

Psychological disorders other

1.9

7.9

114

373

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

7.9

328

1437

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.4

7.8

QDH01

NOMESCO Finland

Excision of nail bed in toe

5.2

7.8

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.0

7.8

V03AE03

ATC

lanthanum carbonate; oral

24.9

7.8

321

Kela drug reimbursment

Paricalcitol and cinacalcet

24.9

7.8

A04

ICPC

Weakness/tiredness general

1.4

7.8

443

2056

A99

ICPC

Disease/condition unspecnature/site

1.8

7.8

148

533

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.9

7.8

107

R33

ICD-10 Finland

Retention of urine

3.0

7.8

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

1.9

7.8

121

408

XQ800

NOMESCO Finland

Prick test

1.6

7.7

235

961

UKC02

NOMESCO Finland

Cystoscopy

1.9

7.7

119

400

E43

ICD-10 Finland

Unspecified severe protein-energy malnutrition

+∞

7.7

JLE70

NOMESCO Finland

Inspection and preparation of pancreas, pre-transplantation

+∞

7.7

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

+∞

7.7

E05.89

ICD-10 Finland

Other thyrotoxicosis

+∞

7.7

2512X

ICD-9 Finland

Other disorders of pancreatic internal secretion, Hypoglycaemia, unspecified[HYPOGLYCAEMIA NUD]

+∞

7.7

A10BD20

ATC

metformin and empagliflozin; systemic

+∞

7.7

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

+∞

7.7

A10BB12

ATC

glimepiride; oral

+∞

7.7

RJ120

NOMESCO Finland

+∞

7.7

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

+∞

7.7

A10BD15

ATC

metformin and dapagliflozin; systemic

+∞

7.7

2500B

ICD-10 Finland

+∞

7.7

N0830, E102

ICD-10 Finland

+∞

7.7

H3600, E113

ICD-10 Finland

+∞

7.7

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

+∞

7.7

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

+∞

7.7

T62

ICPC

Metabolic, Administrative procedure

+∞

7.7

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

+∞

7.7

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

+∞

7.7

N05BA12

ATC

alprazolam; oral

2.0

7.7

103

328

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

7.7

157

SPAT1396

SPAT

Meeting with multidisciplinary group of experts

2.4

7.7

169

N19

ICD-10 Finland

Unspecified kidney failure

6.0

7.7

T93

ICPC

Lipid disorder

3.8

7.7

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

7.7

145

520

R1250

NOMESCO Finland

Evaluation of functional capability

3.0

7.7

Z51.88

ICD-10 Finland

Other specified medical care

4.2

7.7

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

11.7

7.7

E14

ICD-10 Finland

Unspecified diabetes mellitus

34.2

7.7

183

Kela drug reimbursment

Lamotrigin and topiramate

3.2

7.7

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

7.6

2768

16123

R01AD08

ATC

fluticasone; nasal

1.3

7.6

643

3174

SPAT1364

SPAT

Health check-up performed during second study year in students of upper secondary schools, vocational schools etc.

0.8

7.6

506

3975

J96.0

ICD-10 Finland

Acute respiratory failure

8.0

7.6

WX872

NOMESCO Finland

Intensive care

2.6

7.6

142

BE00A

NOMESCO Finland

10.0

7.6

RJ210

NOMESCO Finland

62.2

7.6

RJ420

NOMESCO Finland

62.2

7.6

RJ126

NOMESCO Finland

62.2

7.6

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

62.2

7.6

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

7.6

413

1903

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

1.7

7.6

171

648

L03

ICPC

Low back symptom/complaint

1.3

7.6

593

2894

R5110

SPAT

6.2

7.6

J01CF05

ATC

flucloxacillin; systemic

2.1

7.6

257

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

7.5

155

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.4

7.5

181

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

7.5

175

669

K08.80

ICD-10 Finland

Toothache NOS

1.6

7.5

183

709

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

4.2

7.5

N05BE01

ATC

buspirone; oral

2.8

7.5

113

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.5

2442

14044

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.5

7.5

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.0

7.4

Z01.7

ICD-10 Finland

Laboratory examination

1.5

7.4

229

941

WVA20

NOMESCO Finland

Medicine administration

2.7

7.4

124

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.2

7.4

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.2

7.4

212

F81.3

ICD-10 Finland

Mixed disorder of scholastic skills

2.7

7.4

114

EB1WA

NOMESCO Finland

4.6

7.4

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.5

7.4

141

B02AA02

ATC

tranexamic acid; systemic

2.1

7.4

267

K29.7

ICD-10 Finland

Gastritis, unspecified

3.1

7.4

RS211

NOMESCO Finland

5.0

7.3

Z96.1

ICD-10 Finland

Presence of intraocular lens

5.0

7.3

K03.66

ICD-10 Finland

Tooth plaque

1.5

7.3

263

1118

B07.9

ICD-10 Finland

Verruca simplex

1.8

7.3

131

463

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.0

7.3

279

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

18.7

7.3

F40.2

ICD-10 Finland

Specific (isolated) phobias

3.0

7.3

H02AB02

ATC

dexamethasone; systemic

2.3

7.3

189

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

2.0

7.3

297

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

7.2

308

1357

N06AA12

ATC

doxepin; systemic

3.8

7.2

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

7.2

309

RS222

NOMESCO Finland

3.9

7.2

N03AF02

ATC

oxcarbazepine; oral

2.0

7.2

292

W85

ICPC

Gestational diabetes

4.2

7.2

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

7.2

178

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.9

7.2

R62.0

ICD-10 Finland

Delayed milestone

2.3

7.2

171

N05AF03

ATC

chlorprothixene; systemic

2.5

7.2

135

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

6.6

7.2

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.6

7.2

205

827

D10

ICPC

Vomiting

1.5

7.1

294

1285

R63.4

ICD-10 Finland

Abnormal weight loss

2.4

7.1

160

TQW80

NOMESCO Finland

Local dermatologic skincare

2.7

7.1

120

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

7.1

711

3590

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.1

7.1

256

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

3.8

7.1

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

7.1

136

492

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

22.8

7.1

T85

ICPC

Hyperthyroidism/thyrotoxicosis

22.8

7.1

WW306

NOMESCO Finland

Transfer of stem cells from foreign registered donator

22.8

7.1

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.9

7.0

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.4

7.0

324

1448

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

7.6

7.0

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

7.6

7.0

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

7.0

350

1587

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

0.7

7.0

238

2067

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.3

7.0

R03AC03

ATC

terbutaline; inhalant

1.4

7.0

330

1481

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

7.0

215

883

B34.9

ICD-10 Finland

Viral infection, unspecified

1.7

7.0

163

623

E55

ICD-10 Finland

Vitamin D deficiency

8.3

7.0

S01EA05

ATC

brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)

8.3

7.0

GD1AD

NOMESCO Finland

Thorax CT examination

2.9

7.0

ZX198

NOMESCO Finland

Other local administration

9.3

7.0

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

3.3

7.0

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.8

6.9

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.7

6.9

112

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

4.7

6.9

R01AD09

ATC

mometasone; nasal

1.2

6.9

1109

5914

R73

ICD-10 Finland

Elevated blood glucose level

6.2

6.9

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

6.9

280

F50.8

ICD-10 Finland

Other eating disorders

4.3

6.9

A77

ICPC

Viral disease other/NOS

1.7

6.9

136

495

L92.1

ICD-10 Finland

Necrobiosis lipoidica, not elsewhere classified

31.1

6.9

WW402

NOMESCO Finland

Leucoferesis

31.1

6.9

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.4

6.9

H3600, E109

ICD-10 Finland

+∞

6.9

2594A

ICD-9 Finland

Other endocrine disorders, Dwarfism, not elsewhere classified

+∞

6.9

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

+∞

6.9

E44.0

ICD-10 Finland

Moderate protein-energy malnutrition

+∞

6.9

2510B

ICD-9 Finland

Other disorders of pancreatic internal secretion, Hypoglycaemic coma[COMA HYPOGLYCAEMICUM]

+∞

6.9

E87.2

ICD-10 Finland

Acidosis

+∞

6.9

E88.8

ICD-10 Finland

Other specified metabolic disorders

+∞

6.9

E16.10

ICD-10 Finland

Hyperinsulinism

+∞

6.9

H3601, E109

ICD-10 Finland

+∞

6.9

A10BH05

ATC

linagliptin; oral

+∞

6.9

J45

ICD-10 Finland

Asthma

1.6

6.9

199

807

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.1

6.8

I25.1

ICD-10 Finland

Atherosclerotic heart disease

5.1

6.8

E61.1

ICD-10 Finland

Iron deficiency

2.8

6.8

104

Z02.4

ICD-10 Finland

Examination for driving licence

1.6

6.8

171

666

K08.3

ICD-10 Finland

Retained dental root

2.0

6.8

259

F98.00

ICD-10 Finland

Nonorganic enuresis nocturna

2.4

6.8

150

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.3

6.8

673

3389

T60

ICPC

Metabolic, Result test/procedure

14.9

6.8

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

56.0

6.8

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

56.0

6.8

RD213

NOMESCO Finland

56.0

6.8

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

56.0

6.8

E06.9

ICD-10 Finland

Thyroiditis, unspecified

56.0

6.8

D35.30

ICD-10 Finland

Craniopharyngoma

56.0

6.8

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

6.8

206

J01FA06

ATC

roxithromycin; oral

1.3

6.8

551

2703

L02BA01

ATC

tamoxifen; oral

7.1

6.7

R52.2

ICD-10 Finland

Other chronic pain

2.5

6.7

140

D11

ICPC

Diarrhoea

1.4

6.7

377

1745

A29

ICPC

General symptom/complaint other

1.5

6.7

203

829

G40.89

ICD-10 Finland

Other epilepsy

5.2

6.7

WX722

NOMESCO Finland

PEEP

3.2

6.7

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.8

6.7

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

6.7

320

5AB14

NOMESCO Finland

8.5

6.6

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.6

6.6

172

680

Z51.5

ICD-10 Finland

Palliative care

5.4

6.6

R02

ICPC

Shortness of breath/dyspnoea

1.5

6.6

229

968

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.9

6.6

298

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.5

6.6

216

903

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

6.5

154

591

Z35

ICD-10 Finland

Supervision of high-risk pregnancy

17.1

6.5

RS314

NOMESCO Finland

17.1

6.5

E29.8

ICD-10 Finland

Other testicular dysfunction

17.1

6.5

RS121

NOMESCO Finland

5.0

6.5

K86

ICPC

Hypertension uncomplicated

5.0

6.5

Congenital heart failure surgery

3.5

6.5

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.9

6.5

320

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

6.6

6.5

WW409

NOMESCO Finland

Other aferesis

6.6

6.5

F92.0

ICD-10 Finland

Depressive conduct disorder

2.5

6.5

128

K59.0

ICD-10 Finland

Constipation

1.8

6.5

112

393

IEV99

NOMESCO Finland

Other psychiatric network intervention

2.6

6.5

117

W84

ICPC

Pregnancy high risk

3.7

6.5

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.2

6.4

196

QBA10

NOMESCO Finland

Incision of skin of trunk

3.2

6.4

Z07

ICPC

Education problem

1.9

6.4

297

S29

ICPC

Skin symptom/complaint other

1.3

6.4

417

1979

130

Kela drug reimbursment

Malignant tumour

2.4

6.4

136

R60.9

ICD-10 Finland

Oedema, unspecified

2.9

6.4

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

6.4

122

442

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

6.4

930

4902

RT130

NOMESCO Finland

5.2

6.4

H26.02

ICD-10 Finland

Presenil cataract

12.4

6.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

6.4

560

2777

T29

ICPC

Endocr/metab/nutr sympt/compl other

4.8

6.3

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.7

6.3

121

439

G44.2

ICD-10 Finland

Tension-type headache

1.5

6.3

237

1018

P94.2

ICD-10 Finland

Congenital hypotonia

20.7

6.3

UGC02

NOMESCO Finland

Rigid bronchoscopy

4.6

6.3

C08CA05

ATC

nifedipine; systemic

3.3

6.3

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

6.2

855

4476

K05.1

ICD-10 Finland

Chronic gingivitis

1.5

6.2

212

892

EMB30

NOMESCO Finland

Adenotomy

1.3

6.2

436

2092

XKC03

NOMESCO Finland

Water cystometry

3.2

6.2

-1

ICPC

3.5

6.2

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

6.2

209

878

F31

ICD-10 Finland

Bipolar affective disorder

2.8

6.2

M01AH05

ATC

etoricoxib; oral

1.2

6.2

870

4565

H47.1

ICD-10 Finland

Papilloedema, unspecified

5.0

6.2

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

6.2

111

395

N01

ICPC

Headache

1.2

6.2

787

4085

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

6.6

6.2

N91.4

ICD-10 Finland

Secondary oligomenorrhoea

6.6

6.2

C10AC01

ATC

colestyramine; oral

3.7

6.2

N06AB05

ATC

paroxetine; oral

2.0

6.2

249

ZX108

NOMESCO Finland

Inhalation

4.7

6.1

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

4.7

6.1

N46

ICD-10 Finland

Male infertility

1.9

6.1

285

Z01.2

ICD-10 Finland

Dental examination

1.2

6.1

1515

8412

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.5

6.1

225

961

M04AA01

ATC

allopurinol; systemic

2.6

6.1

102

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

6.1

132

SPAT1234

SPAT

Support of social functional capacity

2.0

6.1

225

E83.1

ICD-10 Finland

Disorders of iron metabolism

28.0

6.1

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

28.0

6.1

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

13.7

6.1

FM2CE

NOMESCO Finland

2.3

6.1

145

Z94.4

ICD-10 Finland

Liver transplant status

7.2

6.1

CJB10

NOMESCO Finland

Laser discission of secondary cataract

7.2

6.1

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.4

6.1

325

1492

N06AA09

ATC

amitriptyline; systemic

2.9

6.1

Z11

ICPC

Compliance/being ill problem

5.1

6.1

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

5.1

6.1

D07XC01

ATC

betamethasone, combinations; topical

1.6

6.0

146

566

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.7

6.0

A04AA01

ATC

ondansetron; systemic, rectal

1.9

6.0

282

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

2.0

6.0

246

S01EE01

ATC

latanoprost; ophthalmic

5.9

6.0

TPX15

NOMESCO Finland

Removal of vascular injection port

7.9

6.0

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

2.1

6.0

213

RK320

NOMESCO Finland

10.7

6.0

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.4

6.0

141

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.8

6.0

108

385

E25.00

ICD-10 Finland

Congenital salt-losing adrenal hyperplasia

+∞

6.0

T43

ICPC

Metabolic, Other diagnostic procedure

+∞

6.0

E89.4

ICD-10 Finland

Postprocedural ovarian failure

+∞

6.0

E25.01

ICD-10 Finland

Congenital adrenal hyperplasia

+∞

6.0

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

+∞

6.0

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

+∞

6.0

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

+∞

6.0

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

+∞

6.0

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

+∞

6.0

T50

ICPC

Metabolic, Medication/prescr/renewal

+∞

6.0

E13.1

ICD-10 Finland

Other specified diabetes mellitus, with ketoacidosis

+∞

6.0

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

+∞

6.0

E83.58

ICD-10 Finland

Idiopathic hypercalciuria

+∞

6.0

E84.8

ICD-10 Finland

Cystic fibrosis with other manifestations

+∞

6.0

4CJ01

NOMESCO Finland

+∞

6.0

E83.3

ICD-10 Finland

Disorders of phosphorus metabolism and phosphatases

+∞

6.0

E03.8

ICD-10 Finland

Other specified hypothyroidism

+∞

6.0

H3601, E113

ICD-10 Finland

+∞

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

8602

28073

1.65

320.57

1.4

1.3

507.7

577.6

titre

2.30

1674

5306

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

9146

30348

1.63

319.47

2.9

2.8

2.4

mmol/l

10.52

7923

26555

(3011985) Renin [Units/volume] in Plasma

1161

1491

4.02

317.39

1.9

1.3

71.5

54.5

mu/l

0.98

1056

1351

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

543

288

9.67

316.15

3.0

1.4

1.3

1.0

ug/l

1.09

503

278

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

7589

24097

1.69

312.64

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

15041

42282

2.09

307.65

2.4

2.0

2.9

2.7

mg/l

11.36

13038

35850

(3001122) Ferritin [Mass/volume] in Serum or Plasma

26767

95030

1.79

307.65

3.4

2.4

114.8

106.1

ug/l

4.97

25105

89244

(3022313) Gas panel - Capillary blood

3071

6675

2.41

307.65

4.9

3.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

5740

11972

2.59

307.65

10.5

5.6

9.6

7.7

mmol/l

69.84

5506

11431

(3009261) Glucose [Presence] in Urine by Test strip

26983

105358

1.56

307.65

3.8

3.0

0.0

estimate

3.85

5312

19245

(1616796) Gas panel - Central venous blood

1704

2807

3.15

307.65

3.9

2.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

12883

43281

1.66

307.65

2.0

1.7

1.1

mg/l

0.39

9731

31895

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1568

1863

4.37

307.65

3.6

2.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

24686

77089

2.08

307.65

2.7

1.9

72.9

1238.4

nmol/l

0.50

22674

70553

(3018095) Leukocytes [#/volume] in Urine

19262

68989

1.62

307.65

4.2

3.1

72.8

82.3

e6/l

1.06

13930

46200

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

48156

210830

1.87

307.65

4.5

2.9

1.4

1.2

mmol/l

307.65

44938

196951

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5164

7797

3.60

307.65

5.0

2.8

94.7

73.8

ng/l

30.24

4594

6833

(3023103) Potassium [Moles/volume] in Serum or Plasma

52934

227186

2.75

307.65

18.6

10.0

4.0

3.9

mmol/l

64.84

51709

219828

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

48674

211152

1.97

307.65

5.1

3.1

6.3

5.5

mmol/l

307.65

45220

195132

(3013826) Glucose [Moles/volume] in Serum or Plasma

33721

109181

2.33

307.65

5.9

3.6

7.2

6.0

mmol/l

307.65

31350

100058

(3023368) Bacteria identified in Blood by Culture

14492

44583

1.87

307.65

4.8

3.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

15143

45963

1.91

307.65

2.8

2.2

3561.8

3515.5

umol/l

0.05

13329

40799

(3009343) pH of Capillary blood

4309

8909

2.58

307.65

4.6

3.6

7.4

7.21

576

959

(3009214) Lutropin [Units/volume] in Serum or Plasma

3594

6422

2.97

307.65

1.6

1.3

8.4

9.1

u/l

2.26

2957

5249

(3021387) Prolactin [Units/volume] in Serum or Plasma

4091

8883

2.44

307.65

2.0

1.3

334.0

290.5

mu/l

4.44

3716

7954

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8742

19620

2.49

307.65

3.1

1.9

23.1

24.5

13.57

7517

16830

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2788

5984

2.44

307.65

3.9

2.7

0.7

0.01

2683

5686

(3030467) Casts [#/volume] in Urine by Automated count

15054

51579

1.65

307.65

3.5

2.6

0.4

e6/l

0.41

11593

37498

(3015377) Calcium [Moles/volume] in Serum or Plasma

18151

59644

1.79

307.65

3.3

3.2

2.3

2.4

mmol/l

3.91

16160

52700

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

49498

219633

1.90

307.65

4.9

3.2

1.4

1.5

mmol/l

307.65

46453

205781

(42870588) Differential panel, method unspecified - Blood

19452

68208

1.67

307.65

6.5

5.9

—

(3022096) Basophils/100 leukocytes in Blood

25513

95431

1.63

307.65

6.9

5.8

0.7

11.69

23955

89355

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

2311

706

17.29

307.65

2.7

1.4

0.8

nmol/l

0.40

1945

640

(3021589) Normoblasts [#/volume] in Blood

25184

93447

1.65

307.65

10.6

7.8

0.0

e9/l

0.11

20823

76451

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

28328

98206

1.90

307.65

6.5

5.6

11.0

11.4

umol/l

4.87

26813

92707

(3013512) EKG study

14521

48642

1.69

307.65

3.9

2.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

6162

16333

2.03

307.65

3.0

2.6

1.8

1.6

31.28

5467

14580

(3000991) Gas panel - Venous blood

5400

12386

2.34

307.65

10.8

7.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8848

26576

1.82

307.65

1.9

1.7

—

(3015736) pH of Urine

21055

79838

1.53

307.65

3.5

2.8

5.7

5.8

0.30

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

6384

16468

2.09

307.65

8.9

6.6

5.1

kpa

0.65

6111

15698

(3006315) Basophils [#/volume] in Blood

28117

105138

1.69

307.65

6.7

5.6

0.0

e9/l

7.23

24594

91725

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1071

629

8.80

307.65

5.4

1.2

96.5

75.5

u/ml

0.34

369

124

(3009508) Creatinine [Moles/volume] in Urine

23348

34773

4.99

307.65

3.8

2.3

8.1

8.5

mmol/l

13.09

20165

29912

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

10073

32743

1.68

307.65

4.0

2.9

439.5

582.7

ng/l

1.83

7206

21930

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

50595

223909

2.03

307.65

5.5

3.4

2.7

2.9

mmol/l

307.65

47535

208509

(3027273) Bicarbonate [Moles/volume] in Venous blood

2965

5701

2.73

307.65

4.3

2.6

25.0

25.4

mmol/l

5.52

2856

5506

(3018418) pH of Serum or Plasma

16979

48533

2.09

307.65

5.1

3.0

7.4

3.49

3574

8599

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

25291

99062

1.52

307.65

4.4

3.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9397

21577

2.45

307.65

2.9

1.9

2.4

g/l

1.90

8736

19943

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

53816

247470

2.17

307.65

12.0

7.8

29.2

26.0

u/l

102.06

52340

238938

(4146454)

858

236

18.75

307.65

2.9

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

6146

12544

2.67

307.65

5.4

3.3

5.8

kpa

0.45

5934

12188

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

714

126

29.17

307.65

7.4

1.8

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4931

12286

2.14

307.65

4.5

2.8

1.2

mmol/l

6.21

4378

10561

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

36608

157978

1.47

307.65

3.7

2.6

52.0

38.7

u/l

123.59

34586

149813

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

6938

11005

3.50

307.65

1.3

1.1

171.9

88.3

iu/ml

41.70

2856

3710

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

40972

156489

2.08

307.65

8.2

6.4

79.3

75.1

u/l

52.88

38913

146962

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

22790

65418

2.26

307.65

2.0

1.6

96.4

97.6

pmol/l

2.78

12476

33986

(3002032) Base excess in Venous blood by calculation

6122

12495

2.66

307.65

5.4

3.3

1.6

1.9

mmol/l

4.30

4931

10200

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3464

7248

2.52

307.65

5.9

3.8

23.8

24.3

mmol/l

12.28

3135

6580

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

20394

65303

1.90

307.65

3.6

3.0

34.5

32.1

u/l

1.50

19367

62273

(3031040) Bacteria [#/volume] in Urine by Automated count

34268

139723

1.59

307.65

4.7

3.6

1217.9

1137.6

e6/l

0.10

564

1648

(3037467) Urinalysis macro (dipstick) panel - Urine

36301

147531

1.65

307.65

4.6

3.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

7396

21667

1.84

307.65

1.9

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

45297

160781

2.85

307.65

5.9

2.3

14.8

14.3

pmol/l

304.72

42432

145832

(3026782) Osmolality of Urine

11372

33922

1.87

307.65

3.1

2.3

547.5

563.6

mosm/kgh2o

8.96

9869

28623

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1818

3083

3.06

307.65

3.7

2.6

24.3

24.6

mmol/l

2.04

1607

2680

(3021960) Folate [Moles/volume] in Serum or Plasma

12457

36522

1.93

307.65

1.6

1.4

19.9

20.3

nmol/l

1.68

11033

31500

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

50716

199080

3.07

307.65

6.8

2.9

2.2

2.1

mu/l

0.25

47785

183386

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6155

17739

1.85

307.65

1.9

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

24303

75124

2.10

307.65

5.7

4.2

35.9

36.4

g/l

30.88

22813

69533

(3027923) C peptide [Moles/volume] in Serum or Plasma

621

160

19.95

307.65

1.7

2.3

1.2

1.5

nmol/l

1.96

488

136

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

27692

85146

2.23

307.65

8.6

4.9

1.2

mmol/l

16.82

23353

72016

(3018010) Neutrophils/100 leukocytes in Blood

26782

101958

1.61

307.65

6.7

5.5

57.1

56.1

37.19

25223

95998

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

19410

65996

1.74

307.65

3.7

2.6

61.4

51.6

ng/l

0.33

12223

36849

(3002582) Erythrocytes [#/volume] in Urine

16528

56676

1.67

307.65

3.6

2.7

64.2

87.4

e6/l

1.46

12986

42129

(3012095) Magnesium [Moles/volume] in Serum or Plasma

10191

24249

2.37

307.65

4.2

3.3

0.8

mmol/l

34.59

9621

22614

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

49843

221317

1.92

307.65

5.0

3.2

4.5

4.9

mmol/l

307.65

47000

207800

(3013115) Eosinophils [#/volume] in Blood

28994

108911

1.69

307.65

7.1

5.8

0.2

e9/l

21.67

25809

96474

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

48378

188422

2.68

307.65

7.4

2.9

42.6

35.9

mmol/mol

307.65

45740

175032

(3019198) Lymphocytes [#/volume] in Blood

28857

108956

1.68

307.65

6.7

5.6

2.0

1.9

e9/l

2.76

25733

96879

(3012516) Albumin [Mass/volume] in Urine

21475

25508

6.15

307.65

3.8

2.1

274.0

912.6

mg/l

28.93

14781

13840

(3003458) Phosphate [Moles/volume] in Serum or Plasma

9177

16935

3.08

307.65

7.6

4.7

1.1

1.0

mmol/l

15.60

8643

15832

(3020630) Protein [Mass/volume] in Serum or Plasma

4320

11318

2.02

307.65

2.5

2.6

66.3

67.0

g/l

6.91

3988

10379

(3020682) Albumin/Creatinine [Ratio] in Urine

22526

26717

6.31

307.65

4.7

2.3

10.5

9.0

mg/mmol

1.15

15663

14438

(3035637) Corticotropin [Mass/volume] in Plasma

1309

1431

4.74

307.65

1.7

1.4

—

(40761511) CBC panel - Blood by Automated count

53041

246225

1.92

307.65

15.5

8.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

31710

121934

1.70

307.65

10.3

8.3

4.2

3.9

e9/l

93.95

27951

106708

(3016502) Oxygen saturation in Arterial blood

5768

14439

2.14

307.65

9.4

7.0

95.6

96.2

9.28

5564

13848

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8574

25363

1.84

307.65

2.6

2.1

29.8

29.7

0.85

8344

24618

(3002173) Hemoglobin [Mass/volume] in Arterial blood

5308

13606

2.08

307.65

9.9

7.2

122.9

123.1

g/l

0.25

5141

13049

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5713

14872

2.06

307.65

2.6

2.3

0.2

g/l

0.35

5311

13952

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

48262

210050

1.92

307.65

14.5

8.7

87.9

ml/min/173m2

0.20

40371

168628

(3019550) Sodium [Moles/volume] in Serum or Plasma

52832

226298

2.75

307.65

18.4

9.9

139.4

139.8

mmol/l

162.99

51684

219498

(3021601) Nitrite [Presence] in Urine by Test strip

26747

104316

1.56

307.65

5.1

4.0

0.0

estimate

2.35

5701

19168

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

20847

81979

1.45

307.65

3.9

3.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

16807

49859

2.00

307.65

2.4

1.9

215.7

214.3

u/l

0.05

15840

47134

(3003181) Sodium [Moles/volume] in Urine

1197

1271

4.87

307.65

1.6

1.3

64.2

71.9

mmol/l

3.94

938

1013

(3002385) Erythrocyte distribution width [Ratio]

44123

198168

1.52

307.65

19.8

11.8

13.6

13.5

64.18

43324

193708

(3006504) Eosinophils/100 leukocytes in Blood

26253

98824

1.63

307.65

6.8

5.7

2.8

2.9

0.48

24626

92484

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

15424

48955

1.82

307.65

1.4

1.2

1.7

1.8

u/ml

0.35

4372

13359

(3003396) Base excess in Arterial blood by calculation

6409

16423

2.11

307.65

8.9

6.5

0.9

1.0

mmol/l

0.67

4999

12751

(3002030) Lymphocytes/100 leukocytes in Blood

27207

103431

1.63

307.65

6.9

5.7

28.4

29.5

48.26

25549

96902

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

6600

6167

6.00

307.65

4.0

1.6

4.6

pmol/l

2.80

5974

5497

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

13739

38847

2.04

307.65

3.2

2.5

1470.5

1003.2

ng/l

18.19

11451

32454

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6931

20908

1.78

307.65

3.4

2.6

8.0

7.9

umol/l

0.13

5982

18089

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4170

8643

2.56

307.65

4.6

3.5

1.5

mmol/l

0.26

2986

6311

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2693

2120

6.72

307.65

2.2

1.2

7.2

8.7

iu/l

0.08

1203

477

(3013707) Erythrocyte sedimentation rate by Westergren method

39055

157736

1.76

307.65

4.3

3.5

11.9

9.5

mm/h

204.72

36568

146794

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4104

9917

2.19

307.65

9.2

7.0

24.6

24.8

mmol/l

2.24

4070

9837

(3012544) pH of Venous blood

6306

13021

2.64

307.65

5.3

3.4

7.4

0.58

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

18010

58863

1.80

307.65

3.1

2.2

55.8

59.4

u/l

6.31

16752

54390

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2863

6119

2.45

307.65

3.9

2.7

1.4

1.3

0.53

2843

6090

(3007164) IgA [Mass/volume] in Serum or Plasma

13229

42679

1.74

307.65

1.5

1.4

2.4

2.2

g/l

11.94

8134

27143

(3032080) INR in Blood by Coagulation assay

20978

68202

1.88

307.65

8.6

6.4

1.2

inr

0.44

6619

20510

(3035350) Ketones [Presence] in Urine by Test strip

26747

104018

1.56

307.65

3.8

2.9

0.0

estimate

0.92

5521

18554

(3001604) Monocytes [#/volume] in Blood

28001

104741

1.68

307.65

6.7

5.6

0.6

e9/l

54.52

24508

91440

(3019069) Monocytes/100 leukocytes in Blood

26392

99383

1.63

307.65

7.1

5.9

8.4

8.5

3.07

24884

93564

(3016244) Insulin [Units/volume] in Serum or Plasma

956

838

5.88

307.65

3.6

2.7

31.6

17.4

mu/l

14.37

899

785

(3004119) Hemoglobin [Mass/volume] in Venous blood

3737

7737

2.56

307.65

4.3

3.0

130.2

132.4

g/l

5.60

3640

7560

(3014111) Lactate [Moles/volume] in Serum or Plasma

5296

13151

2.15

307.65

8.9

6.3

1.4

1.3

mmol/l

6.14

5081

12682

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1276

765

8.65

307.65

2.7

1.4

21.5

20.0

nmol/l

2.95

1223

719

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2667

5391

2.59

307.65

4.7

3.0

50.5

48.9

2.13

2629

5335

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4362

9034

2.57

307.65

4.6

3.6

5.1

kpa

0.04

4063

8392

(3022948) Iron [Moles/volume] in Serum or Plasma

10101

23951

2.38

307.65

2.9

1.9

13.4

15.3

umol/l

1.50

9416

22264

(3000850) Epithelial cells [#/volume] in Urine

11811

38388

1.71

307.65

3.0

2.2

6.2

5.7

e6/l

2.04

10477

33207

(3020564) Creatinine [Moles/volume] in Serum or Plasma

53698

245849

2.20

307.65

18.5

10.6

76.9

73.3

umol/l

80.92

53681

245692

(3023520) Reticulocytes [#/volume] in Blood

4527

11642

2.06

307.65

2.9

2.6

73.0

66.5

e9/l

20.49

3425

8647

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

1012

166

31.54

307.65

1.4

1.3

1.4

1.6

nmol/l

0.78

909

150

(36304419) Bacteria [Presence] in Urine

14723

51547

1.60

307.65

3.4

2.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6094

17596

1.85

307.65

1.8

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

7370

18463

2.18

307.65

8.5

6.4

104.2

105.1

mmol/l

34.47

7207

18103

(40758558) Short blood count panel - Blood

14209

51299

1.54

307.65

7.5

6.6

—

(3026008) Bacteria identified in Urine by Culture

15570

52189

1.70

307.65

3.1

2.5

—

(3004775) Volume in Urine collected for unspecified duration

672

264

13.09

307.65

2.3

2.2

661.1

692.4

0.55

484

209

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6283

18164

1.85

307.65

4.4

235.2

242.6

u/l

2.34

5931

17293

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

454

132

17.63

307.65

2.1

1.3

156.4

26.5

ug/min

1.68

111

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

25089

77250

2.13

307.65

7.8

4.5

1.2

mmol/l

11.12

23078

69676

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

51449

232416

1.97

307.65

16.2

9.8

21.5

22.9

mg/l

16.59

42750

173033

(3044640) Blood type and Crossmatch panel - Blood

17320

62458

1.58

307.65

2.6

2.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

15495

47134

1.91

307.65

1.8

1.5

1.3

mmol/l

127.00

13164

40742

(3024354) Oxygen [Partial pressure] in Venous blood

4975

10475

2.55

307.65

4.6

3.1

4.8

4.7

kpa

2.39

4774

10163

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

2251

636

18.68

307.65

2.5

2.3

128.2

126.6

ug/min

0.03

1470

341

(3027801) Oxygen [Partial pressure] in Arterial blood

6383

16461

2.09

307.65

8.9

6.5

12.2

13.5

kpa

48.14

6112

15687

(3044889) 12 lead EKG panel

35995

140907

1.76

307.65

3.8

2.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

10001

26423

2.11

307.65

1.8

1.6

1184.4

1131.3

nmol/l

6.04

7881

19891

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7881

12842

3.45

307.65

2.3

2.0

368.5

381.2

nmol/l

5.03

7253

11990

(3042936) Bacteria identified in Isolate by Culture

8219

24980

1.78

307.65

2.3

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

12353

31869

2.23

307.65

1.8

1.4

39324653.9

40953524.8

pmol/l

0.09

10477

27070

(3019060) Gas panel - Arterial blood

3686

9022

2.15

307.65

5.4

4.3

—

(3033658) Prothrombin time (PT) actual/Normal

14246

49115

1.63

307.65

4.7

3.4

92.3

92.0

0.51

13826

47923

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

2134

731

15.37

307.65

1.1

4928.3

10.5

iu/ml

0.65

554

178

(3005719) IgG [Mass/volume] in Serum or Plasma

5035

14235

1.87

304.64

2.6

2.7

10.5

10.6

g/l

1.27

4593

13133

(3016750) Collection duration of Urine

502

249

10.34

303.46

2.2

2.3

499.9

510.7

min

0.85

400

199

(3000034) Microalbumin [Mass/volume] in Urine

793

761

5.36

296.71

3.3

1.6

62.8

38.7

mg/l

1.23

615

466

(40768797) Stomach Pathology biopsy report

7627

24584

1.66

295.77

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3528

8869

2.09

295.46

7.9

6.1

24.4

24.6

mmol/l

3.45

3314

8190

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1014

1245

4.20

292.46

1.3

28.2

30.1

nmol/l

0.11

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

13005

47663

1.50

291.17

2.5

2.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3550

9042

2.06

287.18

11.3

8.4

0.7

2.91

3523

8992

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3554

9059

2.06

286.94

11.2

8.3

1.4

0.84

3531

9001

(3022217) INR in Platelet poor plasma by Coagulation assay

6344

19643

1.72

284.02

21.2

19.3

1.3

inr

0.93

941

3049

(3017446) Testosterone [Moles/volume] in Serum or Plasma

5602

16731

1.78

283.77

2.8

1.8

10.8

13.6

nmol/l

100.92

4989

15159

(3014007) Fractional oxyhemoglobin in Arterial blood

3552

9094

2.05

283.37

11.4

8.4

93.8

94.4

5.97

3540

9061

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4207

11517

1.92

278.92

3.1

2.5

186.7

164.8

ng/l

2.40

3758

10327

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2639

6029

2.28

277.51

1.9

1.7

1.5

1.4

g/l

6.60

2294

5075

(3029937) Albumin [Presence] in Urine by Test strip

14677

55566

1.46

277.08

4.2

3.2

0.0

estimate

0.38

5448

18608

(3028026) IgM [Mass/volume] in Serum or Plasma

3991

10758

1.95

276.49

1.8

1.9

1.2

1.4

g/l

7.73

3675

9940

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2671

6202

2.25

270.55

5.1

3.9

24.5

24.7

mmol/l

4.15

2504

5817

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4181

11555

1.90

269.25

1.8

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1869

3681

2.63

266.65

5.2

4.3

8.7

8.8

kpa

0.56

1753

3449

(3010421) pH of Blood

1869

3708

2.62

262.94

4.6

2.8

7.4

7.72

1601

3123

(3021901) Oxygen saturation in Capillary blood

1316

2134

3.19

261.18

3.1

2.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9043

31344

1.55

257.46

3.0

2.4

1.1

1.0

e6/l

1.18

5146

17080

(3007461) Platelets [#/volume] in Blood

55532

268552

1.84

257.41

24.7

14.1

258.2

253.5

e9/l

50.19

54477

261146

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8568

29338

1.57

257.17

3.2

2.5

3.1

2.8

e6/l

1.03

4679

15155

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

815

930

4.51

255.43

1.3

1.2

5.8

5.6

umol/l

0.29

763

864

(3008295) Osmolality of Serum or Plasma

831

966

4.42

255.13

1.7

1.5

282.7

284.1

mosm/kgh2o

0.79

658

751

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

5529

16944

1.73

254.94

3.6

2.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4317

12281

1.85

254.19

2.4

2.0

7.4

7.7

ug/l

0.41

3799

10766

(3041096) Erythrocytes [Presence] in Urine by Automated

15243

58981

1.42

251.31

3.3

2.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1042

1482

3.62

249.65

1.5

1.3

363.9

287.4

pmol/l

1.58

804

1149

(40760892) CBC W Ordered Manual Differential panel - Blood

13174

49669

1.45

249.36

4.9

3.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3389

8932

1.99

249.14

2.1

2.4

—

(3035941) MCH [Entitic mass]

55539

268891

1.82

248.51

24.6

14.0

30.1

30.2

79.09

54973

265109

(3024731) MCV [Entitic volume]

55538

268935

1.82

247.00

24.6

14.0

90.2

90.4

17.11

54971

265131

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3138

8070

2.03

246.43

12.2

8.6

—

(3026361) Erythrocytes [#/volume] in Blood

55541

268977

1.82

246.31

24.7

14.0

4.6

e12/l

0.15

54356

260909

(3023183) Ammonium ion [Moles/volume] in Plasma

1530

2824

2.80

245.45

3.2

2.6

35.6

33.5

umol/l

1.62

1325

2419

(3010813) Leukocytes [#/volume] in Blood

55546

269066

1.82

244.60

24.8

14.1

7.0

6.5

e9/l

307.65

54365

260989

(3000963) Hemoglobin [Mass/volume] in Blood

55548

269119

1.82

243.39

24.9

14.1

136.1

137.2

g/l

49.01

54992

265320

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2083

4557

2.37

240.33

5.5

4.5

1.5

1.2

mg/l

51.28

1956

4271

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1930

4091

2.45

237.92

1.5

1.3

273.0

301.2

ug/g

5.33

1112

2229

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2968

7583

2.04

236.91

11.9

8.7

24.1

24.3

mmol/l

4.02

2774

7151

(3027315) Oxygen [Partial pressure] in Blood

1640

3215

2.64

235.74

4.5

2.9

8.8

kpa

0.03

1606

3138

(3013290) Carbon dioxide [Partial pressure] in Blood

1633

3199

2.64

235.05

4.5

2.9

5.0

kpa

1.61

1600

3122

(3012501) Base excess in Blood by calculation

1632

3199

2.64

234.63

4.5

2.9

2.4

2.2

mmol/l

1.32

1097

2036

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2743

6831

2.09

233.88

2.1

1.5

36.7

42.7

nmol/l

22.97

2680

6710

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1436

2675

2.77

226.53

1.9

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

12480

47297

1.43

226.11

3.8

3.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

2113

4783

2.29

226.07

1.3

90.8

127.3

titre

1.34

196

453

(3034770) Mitochondria Ab [Titer] in Serum

2066

4634

2.31

225.58

1.3

934.2

1000.9

titre

0.13

129

(3017143) Hepatitis C virus Ab [Presence] in Serum

8609

30327

1.52

224.59

1.8

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

4998

15470

1.70

220.71

4.4

4.1

0.9

0.35

1402

3884

(3026250) Tacrolimus [Mass/volume] in Blood

556

504

5.66

219.28

40.0

32.3

7.5

7.3

ug/l

0.76

518

445

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3482

9673

1.88

219.24

1.6

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1969

4404

2.32

216.21

2.2

1.6

181.8

210.1

pmol/l

19.32

1883

4221

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2317

5570

2.16

215.31

6.0

4.5

1.8

0.05

2188

5153

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5467

17510

1.65

212.14

3.0

2.2

43.6

42.7

u/l

0.04

4643

15217

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1883

4169

2.34

211.38

4.4

3.3

0.3

u/ml

0.74

1051

2316

(3007930) Methemoglobin/Hemoglobin.total in Blood

2275

5495

2.15

208.88

6.1

4.6

0.9

0.67

2153

5085

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

423

293

7.39

207.35

1.6

1.1

14.8

13.6

pmol/l

2.02

361

254

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2160

5151

2.18

204.49

2.1

1.9

2.0

2.1

ug/l

0.15

1943

4473

(3021440) Promyelocytes/100 leukocytes in Blood

4740

14780

1.69

202.93

4.5

4.1

0.1

0.21

1303

3597

(36660697) Celiac disease serology panel - Serum

5487

17788

1.63

202.56

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

4107

12381

1.74

198.09

1.5

1.3

21.4

27.5

iu/l

25.54

3463

10714

(40767503) Oxygen content in Capillary blood by calculation

1453

2930

2.56

197.61

2.7

1.9

16.8

17.0

0.65

783

1305

(3002179) Metamyelocytes/100 leukocytes in Blood

4562

14210

1.69

195.73

4.1

3.9

0.6

0.02

1008

2850

(3024928) Oxygen saturation in Venous blood

1408

2860

2.54

188.72

4.6

3.6

—

(3020891) Body temperature

2267

5690

2.07

188.69

5.5

3.9

—

(3025159) Blasts/100 leukocytes in Blood

4486

14049

1.68

188.34

4.5

4.2

0.2

0.11

1090

3062

(3018405) Lactate [Moles/volume] in Arterial blood

1996

4808

2.15

184.15

4.3

3.6

1.4

1.3

mmol/l

5.10

1961

4740

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2083

5110

2.11

183.69

2.6

2.2

712.3

423.0

ug/l

1.10

1936

4708

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2989

8362

1.86

183.31

1.1

3.7

14.4

u/ml

1.18

121

(3008037) Lactate [Moles/volume] in Venous blood

1234

2382

2.67

182.27

3.2

2.5

1.6

1.4

mmol/l

10.61

1201

2338

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3112

8841

1.83

181.95

1.7

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1698

3838

2.29

181.80

1.4

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

494

486

5.21

180.51

1.7

1.4

9.2

2.1

nmol/l

0.86

415

387

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

8535

31340

1.45

177.20

1.9

1.7

1.5

1.4

31.50

7550

28372

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1061

1912

2.86

177.16

1.3

1.2

0.2

0.3

nmol/l

0.23

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

538

595

4.63

174.47

1.6

1.1

598.1

374.3

mu/l

2.93

517

559

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

544

616

4.53

171.96

1.6

1.1

72.8

72.6

0.12

523

580

(3019150) Specific gravity of Urine by Refractometry

11841

46343

1.37

170.50

4.1

3.2

1.0

kg/l

0.06

1773

6784

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1055

1939

2.80

170.22

1.3

1.2

0.7

1.2

nmol/l

0.30

1016

1877

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

9674

36609

1.41

169.69

1.3

31.4

33.6

iu/ml

0.29

2830

11692

(3016038) Potassium [Moles/volume] in Urine

491

511

4.92

169.68

1.7

1.3

34.2

37.6

mmol/l

1.54

431

461

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

332

221

7.68

167.46

1.5

1.3

6.1

5.2

nmol/l

2.88

320

207

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

961

1689

2.93

167.40

1.3

1.2

—

(3000494) Fungus identified in Specimen by Culture

6482

22792

1.50

166.10

1.6

1.4

—

(40761536) Microorganisms panel - Urine sediment

5192

17392

1.57

165.59

4.0

3.1

—

(3012565) Volume of 24 hour Urine

453

450

5.15

164.00

2.2

2.3

2103.9

1965.7

1.11

411

423

(3019225) pH of Specimen

4985

16593

1.58

163.22

5.0

3.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

9113

34338

1.41

163.00

1.3

1.2

10.6

11.0

u/ml

0.18

3716

13909

(3038515) Glucose [Moles/volume] in Venous blood

1135

2224

2.63

162.95

3.4

2.5

8.1

6.2

mmol/l

47.01

1106

2191

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1585

3651

2.24

162.40

7.6

4.6

794.2

1251.3

iu/ml

0.38

251

435

(3008116) Ketones [Moles/volume] in Urine by Test strip

248

107

11.84

161.16

1.5

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

11579

45668

1.36

156.89

1.8

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1262

2665

2.44

156.27

4.0

2.7

999.6

3004.5

u/ml

0.59

148

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1517

3501

2.24

154.70

3.0

3.5

1.9

2.9

ratio

0.91

150

261

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1552

3624

2.21

153.99

3.0

3.5

54.6

38.8

mg/l

0.94

1249

2960

(3034860) Kappa light chains.free [Mass/volume] in Serum

1552

3627

2.21

153.69

3.0

3.5

85.2

55.0

mg/l

0.37

1253

2953

(3001019) Free T4 and TSH panel - Serum or Plasma

4079

13126

1.62

152.93

2.1

1.3

—

(3042733) HLA Ab [Presence] in Serum

407

393

5.30

151.47

5.1

4.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

172

28.31

150.32

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

425

435

5.00

149.41

1.6

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

407

404

5.15

147.50

1.7

1.4

6.4

4.6

mmol/24h

1.44

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1485

3477

2.20

146.35

1.4

1.3

18.8

26.4

u/l

15.84

1250

2895

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

213

13.26

145.91

2.6

2.5

1.6

0.8

mmol/l

2.71

159

(3022689) Creatine [Moles/volume] in Urine

280

181

7.90

144.16

1.4

1.5

—

(3043409) Potassium [Moles/volume] in Arterial blood

1690

4212

2.07

142.75

4.5

3.8

3.9

3.8

mmol/l

3.55

1564

4013

(3017817) Protein [Mass] in Urine collected for unspecified duration

654

997

3.36

142.17

2.8

2.5

0.7

0.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2670

7803

1.78

141.64

2.0

39.2

39.9

u/l

0.82

2393

7169

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2528

7273

1.80

141.17

1.5

1.6

13.3

13.9

u/ml

0.06

260

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1007

2005

2.58

140.18

1.3

35.7

36.0

u/l

0.02

899

1739

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

756

1282

3.03

139.67

19.1

19.6

1476.9

2074.7

nmol/l

0.37

730

1222

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

265

166

8.15

139.36

1.7

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

730

1222

3.06

137.69

13.8

14.0

1573.6

799.5

nmol/l

0.53

707

1172

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1554

3829

2.09

135.10

1.6

1.4

0.4

nmol/l

0.15

1243

3081

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2955

9040

1.70

133.61

3.1

2.3

0.3

e6/l

0.48

2879

8724

(3028271) Lactate [Moles/volume] in Capillary blood

1081

2287

2.43

133.28

2.1

1.5

1.8

1.7

mmol/l

0.22

1061

2223

(3041354) Potassium [Moles/volume] in Venous blood

711

1196

3.05

133.08

2.3

2.0

4.1

4.0

mmol/l

5.90

700

1188

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4389

14852

1.54

132.42

2.7

2.3

67.8

74.8

ml/min/173m2

17.65

1769

5190

(3035285) Chloride [Moles/volume] in Venous blood

709

1195

3.04

132.28

2.3

2.0

105.1

106.2

mmol/l

6.22

698

1186

(40768446) Kidney Pathology biopsy report

427

494

4.42

131.90

1.9

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

585

874

3.43

130.93

2.0

2.1

1.2

1.0

g/24h

0.32

(3033705) Calcium.ionized [Moles/volume] in Venous blood

693

1168

3.04

129.31

2.4

2.0

—

(3048689) Calprotectin [Mass/mass] in Stool

7746

29452

1.39

128.26

2.4

2.6

129.1

126.5

ug/g

0.24

6095

23416

(3037121) Protein [Mass/volume] in Urine

2065

5746

1.86

127.87

3.4

3.2

0.4

0.3

g/l

3.99

1051

2508

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1687

4383

1.99

127.45

1.7

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1787

4740

1.95

127.42

1.9

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1588

4039

2.03

127.07

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

802

1493

2.76

126.48

15.0

2.3

8.2

6.0

mmol/l

18.58

669

1207

(3047181) Lactate [Moles/volume] in Blood

1850

4991

1.91

125.62

7.0

4.8

1.3

1.2

mmol/l

4.98

1643

4372

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2065

5780

1.85

125.54

1.7

1.6

296.2

325.9

titre

0.16

214

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1879

5099

1.90

125.42

2.1

2.2

3.9

3.8

g/l

1.68

1362

3685

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1882

5111

1.90

125.34

2.1

2.2

7.5

7.1

g/l

13.78

1420

3906

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1880

5107

1.90

125.10

2.1

2.2

—

(3000330) Specific gravity of Urine by Test strip

2604

7829

1.72

125.07

3.3

2.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

1338

3203

2.15

124.93

3.8

3.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

1186

2707

2.25

123.93

3.1

3.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1671

4374

1.97

123.63

1.6

1.3

19.4

22.5

u/ml

0.35

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1396

3460

2.08

119.47

2.3

1.9

131.8

133.5

g/l

1.42

1071

2475

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6127

22621

1.42

119.36

7.3

5.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1744

4692

1.92

119.33

1.4

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

47071

225978

1.29

119.13

17.7

10.4

40.0

40.6

39.07

35113

180753

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1656

4382

1.95

118.82

1.5

1.3

261.5

238.6

u/ml

2.30

1068

2768

(3009466) Valproate [Moles/volume] in Serum or Plasma

1158

2665

2.23

118.72

5.9

4.6

371.1

374.3

umol/l

0.27

1034

2296

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1752

4756

1.90

116.74

2.1

2.2

10.1

10.5

g/l

2.68

1493

3985

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1560

4075

1.97

116.03

1.7

1.3

105.3

108.6

u/ml

0.53

328

848

(3036489) Thrombin time

2477

7509

1.71

115.36

2.6

2.2

21.3

0.04

2124

6450

(3019230) Fractional oxyhemoglobin in Venous blood

1122

2588

2.23

114.42

4.5

3.4

65.9

64.8

0.78

1117

2582

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1768

4888

1.87

111.49

2.1

2.2

3.1

3.0

g/l

1.29

1394

3808

(3022806) Fractional oxyhemoglobin in Capillary blood

895

1895

2.42

110.16

2.0

1.5

90.4

90.6

0.55

886

1855

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5374

19657

1.43

109.56

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

444

622

3.65

108.65

27.9

26.4

120.4

124.1

ug/l

0.34

360

541

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

240

188

6.52

107.36

6.2

5.5

—

(3052851) Hemolysis interference index of Serum or Plasma

1819

5144

1.82

106.90

3.3

2.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

864

1831

2.42

106.15

7.7

5.7

11.4

10.6

mg/l

4.99

796

1696

(3036603) Volume of Urine

485

740

3.35

105.41

1.6

1.7

1993.3

2061.3

0.22

106

104

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

641

1167

2.81

105.19

13.2

10.4

0.6

mmol/l

3.23

591

1070

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2046

6039

1.75

104.44

3.4

2.7

3.6

3.5

g/l

4.93

1947

5759

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3819

13202

1.50

103.42

2.6

2.3

5558.7

6582.5

u/l

1.20

1502

5271

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

974

2208

2.27

103.36

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1448

3838

1.94

103.31

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2187

6606

1.71

102.98

3.1

2.5

93.2

92.9

0.16

2032

6158

(40761535) Cells panel - Urine sediment

4174

14721

1.48

102.52

3.8

2.9

—

(3003694) ABO and Rh group [Type] in Blood

16204

70006

1.24

102.02

1.6

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1722

4858

1.83

101.92

2.0

2.1

11.0

10.2

mg/l

1.48

1602

4590

(1002224) Polysomnography panel

2924

9550

1.59

101.87

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1598

4411

1.87

101.18

2.2

2.4

0.5

1.0

g/l

7.68

1401

3822

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1449

3881

1.92

100.32

1.8

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1451

3895

1.92

99.81

2.0

2.1

0.0

g/l

0.20

1336

3592

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5975

22641

1.38

98.86

4.7

3.3

31.0

32.2

14.11

4374

15804

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

672

1304

2.64

98.29

1.1

284.7

512.5

mg/l

0.52

602

1200

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1971

5864

1.73

97.83

1.7

1.8

0.2

g/l

17.86

1877

5572

(3048929) Epstein Barr virus Ab [Presence] in Serum

2715

8796

1.60

97.72

1.4

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2019

6074

1.72

96.36

1.7

1.8

1.2

1.1

g/l

23.58

1923

5794

(44806420)

161

10.01

96.13

2.3

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2465

7885

1.62

93.34

1.3

1.2

0.7

0.9

u/ml

0.55

215

616

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1454

3995

1.87

93.32

2.0

2.1

37.7

38.6

g/l

5.34

1277

3465

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1230

3190

1.98

93.24

1.5

1.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

462

746

3.17

92.33

2.6

1.8

1.9

umol/l

0.29

440

696

(3016650) Hepatitis A virus Ab [Presence] in Serum

1300

3453

1.94

92.16

1.1

—

(3039000) Anion gap in Blood

1279

3378

1.95

92.15

8.4

5.8

11.4

11.0

mmol/l

3.61

1170

3000

(3018572) Chloride [Moles/volume] in Blood

1279

3379

1.95

92.07

8.4

5.8

105.1

105.6

mmol/l

3.33

1170

3001

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1174

3015

2.00

91.42

1.3

1.2

212.5

120.3

titre

0.39

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1332

3591

1.91

90.45

2.1

0.0

g/l

0.49

1221

3300

(46235355) HIV 1 and 2 tests - Meaningful Use set

13596

58234

1.24

90.15

2.1

2.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1385

3789

1.88

90.05

1.9

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1207

3151

1.97

89.84

1.6

0.7

0.8

g/l

1.09

885

2446

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

755

1634

2.37

88.78

1.1

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1314

3550

1.90

88.67

2.1

2.2

0.0

g/l

0.00

1218

3294

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1976

6051

1.68

88.38

3.1

2.6

184.3

172.9

6.25

1891

5727

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

988

2443

2.08

85.03

1.1

1.5

g/l

0.53

898

2238

(3024932) HLA-DR beta [Type]

350

494

3.62

84.91

1.1

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

813

1859

2.24

84.63

1.4

11.7

9.6

mmol/l

1.54

296

(1761868) Lipid panel - Serum or Plasma

19578

87511

1.21

84.32

3.1

2.1

—

(3024471) HLA-A [Type]

354

507

3.57

84.21

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3246

11398

1.47

80.82

1.2

1.1

122.4

240.6

titre

2.99

333

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

411

683

3.08

78.62

2.7

1.9

26.7

29.3

umol/l

4.22

402

657

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1597

4761

1.73

78.57

1.5

1.4

13.8

11.7

iu/ml

0.26

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

711

1585

2.30

78.42

1.4

—

titre

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1237

3415

1.86

78.22

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

149

8.00

77.62

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

476

885

2.75

75.41

2.0

1.3

21.9

27.9

umol/l

3.57

457

846

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1068

2843

1.93

75.24

1.7

1.5

—

(3022145) Colonoscopy Study observation

5731

22462

1.33

74.93

1.4

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

133

8.92

74.34

1.9

9.7

2.3

nmol/l

1.22

127

(40768804) Tissue Pathology biopsy report

19630

88501

1.19

74.24

2.1

2.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

864

2146

2.06

73.54

1.7

1.4

—

(3037756) Immunofixation for Serum or Plasma

972

2546

1.96

71.70

1.6

1.8

—

(21494755) Public health laboratory ask at order entry panel

5183

33936

0.76

71.37

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1031

2764

1.91

71.17

1.9

1.7

—

(3025941) Bacteria identified in Stool by Culture

3502

12790

1.42

70.61

1.3

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

1802

5713

1.62

70.47

2.9

3.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

752

1799

2.14

70.37

2.9

3.0

0.9

0.8

nmol/l

3.45

556

1358

(3001556) Androgen free Index in Serum or Plasma

200

206

4.95

70.14

1.4

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

116

10.19

70.06

7.0

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2217

7403

1.54

69.74

2.1

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2040

6683

1.57

69.73

1.9

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

3971

14857

1.39

69.64

1.4

1.3

258.8

252.0

u/ml

0.08

3656

13792

(3017732) Neutrophils [#/volume] in Blood

3978

14891

1.39

69.54

2.9

2.4

4.3

4.0

e9/l

8.33

3207

12033

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1928

6236

1.59

69.52

2.0

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

666

1522

2.24

69.49

1.2

65.9

72.3

u/l

0.56

481

1013

(4010399)

3685

13632

1.40

69.04

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

3726

13812

1.40

68.98

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

703

1651

2.18

68.81

3.5

2.7

12.7

3.7

nmol/l

0.58

668

1612

(3010015) Selenium [Moles/volume] in Serum or Plasma

139

7.38

68.56

2.5

1.9

1.2

umol/l

0.18

132

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

954

2529

1.93

68.04

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

324

517

3.20

66.10

3.0

2.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

955

2601

1.88

62.95

3.1

1.2

1.5

1.51

737

1994

(3001186) Copper [Moles/volume] in Serum or Plasma

262

378

3.54

61.86

1.6

1.1

16.8

umol/l

0.05

235

339

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

709

1747

2.08

61.67

2.1

2.3

32.6

32.9

0.93

701

1741

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1223

3622

1.73

61.55

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1223

3624

1.73

61.44

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13713

60681

1.19

60.97

4.3

4.4

2.3

3.4

ug/l

6.07

12321

55269

(21494890) Protein electrophoresis panel - 24 hour Urine

525

1145

2.34

60.88

2.0

2.2

—

(3003338) MCHC [Mass/volume]

43689

212108

1.18

60.76

21.1

12.1

332.8

333.6

g/l

59.57

43403

210265

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1307

3976

1.69

59.79

1.4

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

585

1356

2.21

59.14

1.3

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

139

117

6.06

58.83

1.1

4.1

3.7

pmol/l

0.10

(4062490)

772

2003

1.97

58.55

1.4

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

770

2001

1.97

58.14

1.4

1.3

0.4

g/l

0.10

508

1440

(3027135) IgG subclass 1 [Mass/volume] in Serum

770

2002

1.97

58.06

1.4

1.3

6.7

6.8

g/l

0.24

509

1432

(3028192) IgG subclass 2 [Mass/volume] in Serum

770

2002

1.97

58.06

1.4

1.3

2.8

3.0

g/l

1.85

511

1429

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

982

2774

1.81

57.85

1.6

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

894

2452

1.87

57.73

1.2

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

949

2658

1.83

57.44

2.5

2.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1600

5186

1.59

57.14

1.4

497.8

518.3

mg/l

0.49

1525

4950

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1436

4539

1.62

56.79

1.4

3.9

3.5

mmol/l

37.72

1352

4268

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

12347

54413

1.20

56.70

1.7

1.6

—

(3022621) pH of Urine by Test strip

3404

12834

1.37

56.58

3.1

2.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

845

2302

1.88

55.70

1.5

1.3

—

(4035726)

4185

16330

1.33

55.55

1.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

135

118

5.83

55.34

4.1

5.9

2.3

mg/l

0.07

116

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

546

1269

2.20

54.89

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2319

8217

1.45

54.73

1.4

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

226

322

3.58

54.36

1.3

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1429

4576

1.60

53.64

1.5

23.3

29.1

e6/l

0.42

1101

3530

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

734

1931

1.95

53.59

1.5

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1429

4578

1.60

53.55

1.5

1387.5

2329.0

e6/l

0.47

1161

3690

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4303

16944

1.31

53.50

3.8

4.3

35.9

22.7

ug/l

0.73

3440

13171

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

692

1796

1.97

52.49

1.8

1.5

—

(3004451) EKG impression Narrative

287

493

2.97

52.26

1.3

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

674

1738

1.98

52.05

1.7

1.4

1.3

1.5

promille

1.67

513

1347

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1585

5254

1.55

51.40

2.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1675

5628

1.53

51.13

1.3

39.0

34.9

u/ml

0.20

358

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

161

183

4.49

51.05

1.1

1.0

71.3

90.6

ug/l

5.33

145

147

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1343

4304

1.60

50.26

1.3

4.6

3.4

ug/l

3.40

1222

3958

(3002256) Pathology report gross observation

6460

26966

1.25

50.23

1.3

1.2

—

(4306422)

1110

3393

1.68

49.92

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1071

3258

1.68

49.04

1.1

117.7

115.7

1.13

976

2954

(3023511) Choriogonadotropin [Units/volume] in Urine

1962

6877

1.47

48.90

1.4

1.3

—

(3019977) pH of Arterial blood

342

674

2.59

48.87

3.1

2.4

7.4

1.38

226

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

11.39

48.71

11.3

7.8

204.7

583.9

e6/l

0.55

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

224

344

3.32

48.55

1.9

1.3

0.2

0.3

nmol/l

2.80

170

240

(44806118)

722

1963

1.88

47.95

1.7

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2409

8806

1.41

47.94

2.4

2.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

385

813

2.42

47.94

2.6

2.2

138.4

155.3

umol/l

0.43

202

400

(44790048)

722

1964

1.88

47.88

1.7

1.5

—

(44790049)

721

1963

1.88

47.69

1.7

1.5

—

(44790047)

721

1964

1.88

47.61

1.7

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

764

2129

1.84

47.07

1.6

1.4

—

(3016330) Potassium [Moles/time] in 24 hour Urine

143

158

4.61

46.80

1.4

1.2

87.1

77.5

mmol/24h

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1920

6764

1.46

46.63

1.1

4.8

5.3

u/ml

0.19

237

1054

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4565

28900

0.79

46.49

1.7

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

299

565

2.70

46.25

2.3

1.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1539

5204

1.52

45.63

1.3

8.8

9.6

u/ml

0.17

212

832

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1068

3313

1.65

45.48

1.7

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

1324

4332

1.57

45.45

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

398

877

2.32

45.29

1.3

1.2

88.4

84.4

u/l

0.27

358

764

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

636

1692

1.92

45.06

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

257

454

2.89

44.76

2.2

74.2

67.5

ug/l

0.40

252

441

(3044927) Protein electrophoresis panel - Urine

474

1133

2.14

44.66

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1511

5123

1.51

44.25

1.3

4.5

7.8

u/ml

1.17

132

554

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1082

3392

1.63

44.25

1.3

1.2

4.2

3.7

u/ml

0.69

498

1572

(3022493) Free Hemoglobin [Mass/volume] in Plasma

334

687

2.48

43.95

6.0

4.0

2752.6

3455.7

mg/l

0.18

257

472

(3006576) Bicarbonate [Moles/volume] in Blood

254

451

2.87

43.87

8.0

5.7

24.6

25.2

mmol/l

1.27

239

403

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

130

140

4.73

43.75

2.9

2.3

81.5

55.2

pmol/l

0.67

111

124

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1308

4306

1.56

43.74

1.3

1.2

38.9

46.3

u/ml

0.76

126

401

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

384

846

2.32

43.73

1.3

1.2

22.2

21.0

u/l

0.17

339

720

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

550

1406

2.00

43.59

2.9

2.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

361

776

2.38

43.37

1.1

1.2

—

(40768441) Liver Pathology biopsy report

502

1243

2.06

43.29

1.5

1.4

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

7.55

43.27

1.7

1.2

13.8

7.5

pmol/l

1.52

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1110

3524

1.61

43.19

1.3

1.2

3.5

3.6

u/ml

0.03

380

1248

(3029634) Reagin Ab [Titer] in Serum by VDRL

1109

3533

1.61

42.56

2.2

2.1

4.6

6.6

titre

0.45

123

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

137

160

4.36

42.25

5.1

47.7

29.0

ug/min

2.20

102

107

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

3029

19955

0.76

42.14

1.4

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1031

3234

1.63

42.09

1.5

1.3

7.7

6.3

mmol/l

29.02

774

2279

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2190

8064

1.40

41.75

1.6

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

393

894

2.24

41.68

1.6

5.7

5.2

u/l

0.21

197

450

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

498

1250

2.04

41.47

2.9

2.2

97.8

97.2

0.13

469

1155

(37021550) Renin [Units/volume] in Plasma --upright

160

216

3.78

41.46

1.5

1.1

138.6

46.2

mu/l

1.28

125

170

(3010370) Gastrin [Moles/volume] in Serum or Plasma

153

200

3.90

41.30

2.4

1.3

36.8

37.9

pmol/l

0.05

132

173

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

368

821

2.29

40.80

1.1

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

453

1107

2.09

40.45

1.6

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1079

3458

1.60

40.43

1.1

—

(3045414) Leukocytes [Presence] in Urine

2395

9000

1.37

40.39

1.9

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1079

3459

1.60

40.39

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

615

1680

1.87

40.36

1.6

1.4

32.5

35.2

g/l

5.34

558

1540

(3006922) Hepatitis E virus Ab [Presence] in Serum

546

1436

1.94

40.04

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

836

2520

1.70

39.66

3.1

3.0

501.6

649.7

u/ml

0.11

791

2343

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

9.25

39.57

3.6

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1040

3328

1.60

39.23

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

537

1417

1.94

39.03

1.4

12.2

11.2

umol/l

2.70

504

1362

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

7.32

38.90

3.1

1.1

69.1

1.7

pmol/l

0.86

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

385

899

2.19

38.47

1.3

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1596

5636

1.45

38.29

1.3

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3819

15468

1.27

37.86

2.3

21.8

22.3

au/ml

0.10

202

1181

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

660

1883

1.79

37.83

1.8

1.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1206

4031

1.53

37.74

1.2

8.4

17.3

u/ml

0.65

(3000093) Morphology [Interpretation] in Blood Narrative

568

1546

1.88

37.72

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

139

183

3.87

37.24

2.5

1.3

8.0

6.1

mmol/l

3.63

122

(3006270) Folate [Moles/volume] in Blood

504

1323

1.95

37.21

1.2

1.1

376.9

385.5

nmol/l

0.38

442

1219

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

376

886

2.17

36.79

1.3

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

571

1571

1.86

36.72

1.2

220.0

198.1

titre

0.08

(3042111) Morphology [Interpretation] in Bone marrow Narrative

795

2416

1.68

36.65

1.8

1.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

571

1572

1.86

36.65

1.2

192.5

219.2

titre

0.28

284

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

156

227

3.50

36.65

2.4

2.7

53.8

20.7

mg/l

1.04

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

507

1341

1.93

36.64

1.1

—

(3018133) Calcium [Moles/volume] in Urine

181

292

3.16

36.59

2.5

2.7

2.6

mmol/l

0.32

168

261

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

504

1332

1.93

36.51

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

163

246

3.38

36.38

3.8

2.1

1.2

mmol/l

0.01

155

234

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1220

4123

1.52

36.32

1.2

5.4

5.1

u/ml

0.05

327

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

211

377

2.85

36.17

3.4

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

211

377

2.85

36.17

3.3

2.4

—

(3020491) Glucose [Moles/volume] in Blood

503

1340

1.92

35.62

2.0

1.4

7.1

5.7

mmol/l

15.22

374

1080

(3051651) Icteric interference index of Serum or Plasma

395

965

2.09

35.38

4.4

3.3

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

496

1320

1.92

35.24

3.0

2.9

30.1

28.7

ug/l

—

(3023419) Bacteria identified in Sputum by Culture

643

1866

1.76

34.88

3.3

2.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3512

14218

1.27

34.87

1.3

40.9

49.1

au/ml

1.05

129

619

(3051387) C reactive protein [Mass/volume] in Capillary blood

1186

4022

1.51

34.76

3.6

2.7

26.5

mg/l

0.01

767

2374

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1597

5745

1.43

34.72

3.3

3.8

2802.6

2021.8

u/ml

0.16

1383

4932

(3017569) Oxygen content in Arterial blood

260

533

2.49

34.58

2.2

2.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

163

255

3.26

34.55

1.3

1.1

402.9

266.7

pmol/l

0.68

109

204

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

592

1684

1.80

34.32

1.8

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

21.38

34.24

9.1

5.3

—

(4268621)

764

2346

1.67

33.93

2.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

946

3078

1.57

33.36

3.4

395.0

620.4

u/ml

0.56

870

2789

(3023487) Leukocytes [#/volume] in Peritoneal fluid

219

419

2.67

33.29

2.6

1.6

4144.9

4983.1

e6/l

0.08

154

270

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

503

1372

1.87

33.27

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

503

1372

1.87

33.27

1.8

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

503

1372

1.87

33.27

1.8

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

103

116

4.52

33.17

1.3

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

738

2262

1.67

33.02

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

589

1694

1.78

32.96

4.1

2.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

737

2261

1.67

32.87

1.5

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

757

2342

1.65

32.70

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

742

2285

1.66

32.62

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

735

2258

1.66

32.61

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1305

4576

1.46

32.50

1.5

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

5.42

32.42

1.3

446.7

295.8

mg/24h

0.16

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

346

837

2.11

31.83

1.6

1.4

—

(3017704) Immunofixation for Urine

284

632

2.29

31.81

1.5

1.8

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

131

187

3.57

31.67

1.5

1.6

0.5

0.4

ug/l

0.98

145

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

147

228

3.29

31.61

3.4

2.1

1.2

mmol/l

0.31

139

214

(3014765) Yersinia sp identified in Stool by Organism specific culture

1673

6177

1.39

31.39

1.2

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

427

1126

1.94

31.22

1.3

362.2

614.4

u/l

2.66

411

1069

(42529406) Shigella sp [Presence] in Stool by Culture

1678

6205

1.39

31.20

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

196

366

2.73

31.18

2.4

1.6

13994.3

12888.5

e6/l

0.04

103

182

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1657

6123

1.39

30.94

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

402

1044

1.97

30.70

1.5

5.9

u/l

0.03

338

884

(3023199) Leukocytes [#/volume] in Pleural fluid

546

1572

1.77

30.49

1.6

1.4

2528.5

3897.5

e6/l

1.22

390

1140

(3024522) Salmonella sp identified in Specimen by Organism specific culture

734

2296

1.63

30.43

1.5

1.4

—

(40762365) Oxygen content in Arterial blood by calculation

114

151

3.85

30.41

2.6

2.7

15.1

15.0

ml/dl

0.09

106

140

(3011288) Drugs identified in Urine by Screen method

2471

9734

1.30

30.25

3.4

3.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

332

809

2.09

30.03

2.5

2.2

45.6

59.7

umol/l

0.49

104

(3012898) Urea [Moles/volume] in Urine

118

4.27

29.98

1.7

1.8

153.3

189.1

mmol/l

1.49

111

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

485

1357

1.83

29.73

1.2

1.1

ratio

0.14

171

474

(3026692) Albumin [Mass/volume] in Peritoneal fluid

160

274

2.98

29.55

1.5

1.3

12.2

14.0

g/l

1.23

115

200

(3049717) Cytology report of Urine Cyto stain

1607

5955

1.38

29.52

2.5

2.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

874

2884

1.55

29.07

1.4

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

760

2427

1.60

29.04

1.2

1.1

96.8

95.3

0.79

718

2270

(4198724)

509

1457

1.78

29.01

2.2

2.5

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

387

1013

1.95

28.94

1.2

14.1

8.4

u/ml

0.38

105

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

307

737

2.13

28.85

1.2

1.1

82.6

76.6

u/l

0.42

236

607

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

605

1824

1.69

28.84

1.6

1.5

—

(3013727) Leukocytes other/100 leukocytes in Blood

217

447

2.48

28.70

3.6

3.0

54.2

50.5

1.37

208

431

(4034850)

1694

6368

1.36

28.51

10.9

7.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

305

735

2.12

28.40

1.2

1.1

20.9

18.7

u/l

0.31

223

582

(3036782) Glucose [Moles/volume] in Pleural fluid

454

1264

1.83

28.29

1.4

1.3

6.8

5.4

mmol/l

13.78

423

1161

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1871

7163

1.34

27.98

1.7

1.6

8.9

5.5

iu/ml

0.17

416

1430

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

256

579

2.25

27.74

2.3

2.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2108

8230

1.31

27.54

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3272

13527

1.24

27.03

1.1

1.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

775

2532

1.56

26.96

1.3

1.2

55.7

52.6

u/ml

0.11

154

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

386

1037

1.90

26.84

1.8

1.7

142.3

128.4

2.56

362

985

(4094501)

1354

4955

1.40

26.81

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

287

693

2.11

26.64

1.4

—

(40768443) Skin Pathology biopsy report

2163

8516

1.30

26.58

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

287

694

2.11

26.54

1.4

—

(3012441) Differential panel - Pleural fluid

473

1362

1.77

26.49

1.6

1.4

—

(3000492) Spirometry study

5255

22819

1.19

26.39

1.5

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

518

1535

1.72

26.31

1.3

1.2

2.0

1.9

mmol/l

1.01

478

1432

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

496

1455

1.74

26.10

3.8

4.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

124

200

3.16

25.26

2.4

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2299

9187

1.28

25.24

1.9

1.8

—

(3047189) Immunofixation for 24 hour Urine

233

529

2.25

25.09

1.7

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

298

752

2.02

24.74

1.7

1.4

—

(3033799) Differential panel - Peritoneal fluid

181

368

2.51

24.66

2.2

1.6

—

(40768806) Pleura Pathology biopsy report

468

1379

1.73

24.30

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2759

11325

1.25

24.26

2.5

2.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

501

1507

1.70

24.18

2.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.44

24.14

6.8

2.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

481

1436

1.71

23.86

1.5

1.4

73806.9

49712.6

e6/l

0.66

283

859

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

379

1055

1.83

23.74

1.1

—

(3045788) Cell count panel - Pleural fluid

426

1230

1.77

23.71

1.6

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1155

4204

1.41

23.64

2.4

2.3

6.8

6.1

umol/l

0.51

858

3081

(3035880) pH of Pleural fluid

271

672

2.06

23.58

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

296

761

1.98

23.40

1.7

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

413

1191

1.77

23.10

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

271

678

2.04

23.06

3.7

3.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

358

990

1.84

22.91

1.0

1.1

99.8

95.5

1.51

290

783

(3011412) CD3 cells [#/volume] in Blood

642

2087

1.57

22.91

2.5

2.6

1.3

1.2

e9/l

0.91

397

1187

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

169

345

2.50

22.88

8.0

7.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.80

22.78

3.6

5.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

438

1292

1.73

22.70

2.0

1.8

2.4

u/field

1.37

202

615

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

298

779

1.95

22.52

2.6

2.2

152.5

148.3

nmol/l

0.22

261

673

(3044007) Cell count panel - Peritoneal fluid

168

345

2.48

22.49

2.5

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

8.85

22.44

3.6

2.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

153

300

2.60

22.42

8.1

6.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

585

1873

1.59

22.26

3.7

3.6

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

137

254

2.75

22.25

1.5

1.2

23.3

27.9

g/l

2.11

101

190

(3016018) Differential panel - Cerebral spinal fluid

699

2337

1.53

22.07

1.6

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

369

1043

1.80

22.07

1.5

1.4

12.8

11.4

u/l

3.17

359

1012

(3000012) Reticulocyte production index

294

772

1.94

21.95

1.4

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

521

1630

1.63

21.76

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

528

1659

1.62

21.69

2.2

2.3

72.6

72.8

0.10

505

1602

(3017354) Segmented neutrophils/100 leukocytes in Blood

536

1691

1.62

21.67

3.0

3.3

58.8

57.4

0.62

329

1096

(3045716) Anion gap in Serum or Plasma

263

667

2.01

21.62

2.5

9.6

8.9

mmol/l

1.38

200

480

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1614

6287

1.31

21.48

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1143

4224

1.38

21.45

1.7

1.6

11976.2

11848.2

e6/l

0.03

820

3115

(3042631) Mycobacterium sp identified in Specimen

622

2041

1.56

21.36

2.7

2.5

—

(3014271) Vancomycin [Susceptibility]

234

573

2.08

21.10

3.0

2.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

244

610

2.04

20.86

1.2

0.3

0.5

g/l

0.65

(3046904) Somatotropin [Units/volume] in Serum or Plasma

11.63

20.80

2.0

1.1

3.1

1.4

mu/l

1.02

(3021788) Differential panel - Synovial fluid

906

3235

1.43

20.69

1.6

1.5

—

(3003129) Base excess in Capillary blood by calculation

154

318

2.47

20.44

1.6

1.7

0.5

0.6

mmol/l

0.06

146

296

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

327

913

1.83

20.38

1.5

24.9

22.3

u/ml

0.37

178

(3025315) Body weight

4.10

20.33

4.4

3.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

517

1645

1.60

20.24

2.2

2.3

12.9

13.5

0.38

271

849

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

357

1027

1.77

20.21

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

1176

4410

1.36

20.21

2.2

1.9

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.51

20.08

3.7

4.8

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

8.73

20.03

1.0

1.2

144.8

370.4

pmol/l

0.95

(3013336) Amino acids [Identifier] in Serum or Plasma

4.63

19.98

2.8

1.7

—

(3045424) Erythrocytes [Presence] in Urine

932

3370

1.41

19.88

1.5

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

506

1609

1.61

19.87

1.1

32.4

69.4

u/ml

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

354

1023

1.77

19.76

1.3

70.5

70.8

0.02

118

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

280

755

1.89

19.44

1.6

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

280

755

1.89

19.44

1.6

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

396

1189

1.70

19.37

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

528

1708

1.58

19.33

1.4

1.3

29.8

33.5

nmol/l

2.00

472

1595

(3019832) Treponema pallidum Ab [Presence] in Serum

7761

35451

1.13

19.31

1.8

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

363

1065

1.74

19.26

1.1

5.3

5.6

nmol/l

0.03

208

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

398

1199

1.69

19.24

1.5

1.3

5.7

5.2

mmol/l

5.84

371

1147

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

114

209

2.78

18.97

8.2

7.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

272

734

1.89

18.86

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

467

1477

1.61

18.78

1.2

—

(3042517) Benzodiazepines panel - Urine

155

335

2.36

18.76

2.7

3.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

932

3409

1.40

18.65

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

469

1489

1.61

18.58

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

150

3.12

18.57

3.5

3.1

—

(3023410) Appearance of Cerebral spinal fluid

650

2225

1.49

18.48

1.8

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

26.30

18.41

5.3

2.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

187

444

2.15

18.29

1.3

1.2

133.6

125.1

nmol/l

0.19

148

330

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

310

883

1.79

18.20

2.6

54.6

52.5

umol/l

0.55

261

775

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

262

707

1.89

18.19

1.1

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

394

1203

1.67

18.17

1.4

1.5

7.1

7.2

ug/l

0.02

350

1089

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

204

503

2.07

18.16

2.1

2.5

109.9

105.6

ng/l

0.13

148

268

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

690

2400

1.47

18.14

1.1

30.8

12.0

au/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

36361

179109

1.09

18.10

3.5

3.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

132

269

2.50

18.06

1.4

75.6

103.9

ng/l

0.47

152

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10546

49226

1.11

17.82

3.9

3.8

22.3

21.2

8.03

4351

22241

(3017315) Amylase [Enzymatic activity/volume] in Urine

333

977

1.74

17.72

1.3

1.2

306.7

357.8

u/l

0.34

297

931

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

115

221

2.65

17.62

8.5

6.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

462

1486

1.59

17.39

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

138

293

2.40

17.39

3.4

4.7

41.3

68.2

u/l

1.08

109

(3023436) Glucagon [Mass/volume] in Serum or Plasma

4.72

17.38

1.9

1.5

198.2

176.5

ng/l

1.06

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

143

3.10

17.38

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

505

1662

1.55

17.24

1.2

1.1

—

(3051339) Copper [Moles/volume] in Blood

3.98

17.19

1.2

16.3

umol/l

0.03

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

504

1660

1.55

17.15

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

504

1661

1.55

17.11

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

152

342

2.26

16.91

1.2

1.3

—

(3005570) Glucose [Moles/volume] in Urine

544

1829

1.52

16.89

2.0

1.7

71.7

6.0

mmol/l

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

499

1646

1.55

16.88

1.2

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

3.85

16.77

1.5

1.2

18.8

18.6

pmol/l

0.02

(21494815) CD4 cells/100 lymphocytes in Specimen

563

1910

1.50

16.76

2.5

2.3

42.1

41.3

0.16

266

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

373

1148

1.66

16.74

1.8

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

497

1644

1.54

16.62

1.2

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

174

418

2.12

16.59

1.6

1.3

62.7

61.9

0.09

141

347

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

497

1646

1.54

16.53

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

623

2166

1.47

16.47

1.1

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

231

619

1.90

16.43

2.8

2.9

28.3

28.6

umol/l

0.17

156

488

(3016879) Cocaine [Presence] in Urine

3179

13759

1.19

16.41

2.4

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

300

875

1.75

16.34

2.1

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

300

875

1.75

16.34

2.1

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

300

875

1.75

16.34

2.1

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

300

878

1.74

16.16

2.1

2.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

359

1105

1.66

16.13

1.1

1551.4

1452.4

miu/ml

0.82

359

1105

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

229

616

1.89

16.12

2.4

1.9

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

9.82

16.10

1.9

1.0

—

(3044941) Cell count panel - Synovial fluid

747

2702

1.41

16.02

1.5

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

239

655

1.86

15.92

2.0

1.5

17561.6

15083.7

u/ml

0.05

(3004616) Nuclear Ab [Presence] in Serum

662

2348

1.44

15.81

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

134

294

2.32

15.80

2.4

2.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

477

1587

1.53

15.58

2.5

2.7

541.8

519.9

e6/l

0.35

395

1309

(3008898) HLA-B27 [Presence]

2207

9283

1.22

15.49

1.1

—

(21494434) Karyotype in Bone marrow

415

1341

1.58

15.40

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

3387

14816

1.17

15.39

2.4

2.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

540

1850

1.49

15.39

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

266

763

1.78

15.36

1.1

92.4

92.3

0.02

127

346

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

129

283

2.32

15.23

1.9

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

397

1274

1.59

15.17

1.8

1.9

4.4

3.0

mg/l

5.87

374

1216

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2316

9810

1.21

15.15

1.3

220.6

230.9

miu/ml

0.63

990

4843

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

472

1577

1.53

15.14

2.6

2.7

791.8

688.2

e6/l

1.62

173

657

(3023420) DNA double strand Ab [Units/volume] in Serum

656

2343

1.43

15.12

1.5

1.6

26.3

36.5

iu/ml

1.04

116

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

273

794

1.75

15.07

2.0

1.7

168.6

148.0

1.94

260

741

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

397

1277

1.59

15.03

1.1

1.0

u/l

0.00

184

550

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2311

9809

1.21

14.80

1.9

1.5

4.3

3.0

mg/l

5.14

1838

6155

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

569

1987

1.46

14.78

1.1

1.2

41.7

41.8

mg/l

0.02

476

1666

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

268

781

1.75

14.71

1.2

111.2

107.0

0.87

246

699

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

465

1560

1.52

14.66

2.5

2.8

0.2

e9/l

2.19

395

1309

(3004716) Salmonella sp identified in Stool by Organism specific culture

3141

13719

1.17

14.55

1.4

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

105

3.25

14.46

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

308

939

1.67

14.42

1.3

13.2

15.7

u/l

0.77

286

879

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

551

1922

1.46

14.41

1.1

255.5

256.5

mg/l

0.03

481

1708

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

277

822

1.72

14.30

1.2

—

(3028300) Cannabinoids [Presence] in Urine

3402

14977

1.17

14.26

2.4

2.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

257

747

1.75

14.25

1.2

1.1

92.4

92.9

0.06

126

339

(3027008) Opiates [Presence] in Urine

3393

14939

1.16

14.21

2.3

2.0

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

716

2629

1.39

14.15

1.1

1.7

2.2

iu/ml

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

461

1558

1.51

14.07

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

280

840

1.70

13.92

1.3

1.2

278.2

360.4

titre

0.25

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

337

1062

1.62

13.91

1.7

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

295

898

1.67

13.91

1.2

1.1

3.9

4.3

iu/ml

0.27

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

470

1602

1.50

13.80

1.4

1.3

0.8

1.4

u/ml

1.06

206

656

(3037556) Urate [Mass/volume] in Serum or Plasma

160

402

2.03

13.71

1.4

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

223

631

1.80

13.54

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

483

1663

1.48

13.51

1.6

1.5

33.1

34.1

0.20

292

1062

(3051593) INR in Capillary blood by Coagulation assay

210

584

1.83

13.47

9.5

8.6

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

153

2.73

13.38

1.4

1.3

17.2

16.1

nmol/l

0.18

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

581

2078

1.43

13.36

2.3

1.9

23.9

26.7

mg/l

0.61

171

535

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

270

812

1.69

13.33

1.3

60.0

101.7

titre

0.96

(3045142) Bone marrow Pathology biopsy report

518

1814

1.46

13.32

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

150

372

2.05

13.32

1.3

3.4

3.5

mmol/l

0.11

137

342

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

662

2426

1.39

13.27

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

137

329

2.12

13.20

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

221

630

1.79

13.12

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

356

1157

1.57

12.99

2.7

2.8

41.2

39.0

0.89

130

376

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

101

214

2.40

12.92

1.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

105

227

2.36

12.88

1.5

302445.7

150269.1

nmol/l

0.27

191

(3035320) C reactive protein [Mass/volume] in Body fluid

426

1444

1.50

12.88

2.7

2.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

173

458

1.92

12.88

1.1

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

612

2227

1.40

12.81

1.6

56.0

53.9

0.59

375

1465

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

497

1741

1.46

12.79

1.8

2.0

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

537

1910

1.43

12.75

2.1

2.0

24.8

24.2

ug/l

0.07

529

1878

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

232

679

1.74

12.63

4.0

3.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

119

276

2.20

12.49

1.2

1.1

1.2

0.7

umol/24h

0.49

148

(3006245) CD3-CD19+ cells/100 cells in Blood

301

950

1.62

12.42

2.4

2.6

12.0

10.6

1.04

284

891

(3010503) CD19 cells [#/volume] in Blood

365

1211

1.54

12.21

2.7

2.6

0.2

0.3

e9/l

0.27

350

1190

(3021162) Amylase [Enzymatic activity/volume] in Specimen

105

233

2.30

12.20

3.2

2.6

3009.5

2079.6

u/l

0.31

206

(3027944) Amphetamines [Presence] in Urine

3312

14737

1.15

12.05

2.2

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

218

636

1.75

12.03

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2499

10887

1.18

11.98

3.0

3.1

39.2

43.9

u/ml

0.52

2415

10548

(3029075) Extractable nuclear Ab panel - Serum

211

611

1.76

11.94

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

144

368

1.99

11.87

1.6

1.4

3.6

2.4

0.64

122

311

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

289

914

1.61

11.85

2.2

2.4

27.5

28.9

1.06

275

867

(3011048) Pyruvate [Moles/volume] in Blood

140

2.69

11.83

1.2

1.5

85.5

81.5

umol/l

0.33

127

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

825

3189

1.32

11.82

1.9

1.7

2838.0

3783.8

titre

0.33

148

(3009871) Measles virus Ab [Titer] in Serum

252

770

1.67

11.81

1.7

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

161

430

1.91

11.74

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

592

2177

1.39

11.70

1.1

—

(4027681)

444

1554

1.46

11.53

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

424

1472

1.47

11.48

1.6

1.4

67.3

70.3

umol/l

0.48

148

(3045462) Protein/Creatinine [Ratio] in Urine

117

280

2.13

11.44

4.1

6.0

443.1

88.0

g/mol

0.42

108

257

(44806071)

114

271

2.14

11.34

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.12

11.09

1.8

2.0

55.2

59.5

0.30

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

173

483

1.82

11.07

1.2

1.1

82.8

88.5

0.68

112

(40757373) Influenza virus identified in Isolate

122

303

2.05

10.89

1.8

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.04

10.85

1.2

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

234

718

1.66

10.84

1.2

108.7

109.9

0.29

206

650

(3016228) CD19 cells/100 cells in Blood

248

773

1.63

10.83

2.2

2.0

8.9

8.5

0.19

238

763

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

172

483

1.81

10.82

1.2

1.1

73.6

77.1

0.31

107

(40761539) Cells [Type] in Urine sediment by Light microscopy

152

410

1.89

10.81

1.3

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

250

782

1.63

10.77

1.2

0.3

g/l

1.93

201

618

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

194

567

1.74

10.71

2.1

1.9

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

196

575

1.74

10.68

1.1

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

170

2.43

10.66

1.2

1.7

mmol/l

0.01

107

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

541

1996

1.38

10.55

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

326

1092

1.52

10.53

1.1

11.6

11.2

u/ml

0.05

202

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

467

1685

1.41

10.37

1.8

1.7

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.98

10.29

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

956

3842

1.27

10.28

1.1

2.8

2.9

u/ml

0.17

443

2059

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

143

2.53

10.16

1.3

515.8

65.9

u/l

0.61

107

(3024263) Appearance of Synovial fluid

280

914

1.56

10.16

2.0

1.8

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

225

2.17

9.94

1.2

1.5

1.9

mmol/l

2.67

134

(3032057) Clostridioides difficile [Presence] in Stool

118

301

2.00

9.87

1.9

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

498

1836

1.38

9.80

1.6

2.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

319

1082

1.50

9.76

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

169

489

1.76

9.70

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

141

2.49

9.62

2.1

2.7

20.6

21.5

mmol/l

0.12

126

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

269

882

1.55

9.61

1.2

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.45

9.54

1.4

1.2

527.4

473.2

nmol/l

0.20

(3000919) Neutrophils/100 leukocytes in Pleural fluid

124

328

1.93

9.40

1.6

1.3

25.3

22.3

0.49

115

294

(3038026) Centromere Ab [Units/volume] in Serum

414

1490

1.42

9.38

1.2

62.0

47.3

u/ml

0.33

(3037692) Legionella sp identified in Specimen by Organism specific culture

188

567

1.69

9.36

1.7

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1925

8390

1.17

9.26

1.9

1.7

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

446

1631

1.39

9.24

1.2

—

(3028433) Virus identified in Specimen by Culture

212

663

1.63

9.22

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

238

767

1.58

9.18

2.2

2.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

183

2.25

9.17

1.6

1.4

7.4

11.4

0.95

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

406

1463

1.41

9.15

1.2

35.1

46.0

u/ml

0.42

103

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

363

1282

1.44

9.12

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

167

492

1.73

9.06

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.36

9.00

6.8

5.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.13

8.97

1.1

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

157

456

1.75

8.94

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

404

1461

1.41

8.94

1.2

64.6

67.1

u/ml

0.06

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

156

454

1.75

8.83

1.8

1.9

47.2

40.0

u/l

0.17

141

414

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

389

1401

1.42

8.82

1.2

13.3

9.2

u/ml

0.28

109

(3043410) Blood group antigens tested for on Red Blood Cells

164

485

1.72

8.79

1.9

1.5

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

172

516

1.70

8.77

1.3

109.1

102.2

1.79

166

485

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

217

2.11

8.76

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1665

7206

1.18

8.74

1.4

1.3

—

(4024509)

445

1643

1.38

8.74

1.6

1.5

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

133

2.45

8.68

2.2

1.8

178.5

164.2

ug/g

0.25

117

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.16

8.66

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

217

695

1.59

8.62

2.3

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

217

695

1.59

8.62

2.3

2.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

295

1013

1.48

8.58

1.6

2.8

2.4

u/field

0.25

228

705

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

336

1184

1.45

8.58

1.8

1.6

1893527.9

1692596.0

iu/ml

0.13

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

3.04

8.55

1.7

2.1

19.2

15.6

0.24

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

167

501

1.70

8.53

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

125

2.48

8.51

1.5

1.3

106.8

113.4

ug/l

0.17

100

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

207

2.12

8.43

1.5

1.7

1.4

2.3

mg/l

1.12

138

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

7.21

8.39

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

166

500

1.69

8.37

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

201

637

1.61

8.35

1.7

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

168

508

1.68

8.35

1.7

1.6

9.7

8.3

ug/l

3.22

168

508

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

219

710

1.57

8.29

2.3

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

197

624

1.61

8.21

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

223

2.05

8.21

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1532

6621

1.18

8.21

1.2

—

(3049233) Organic acids panel - Urine

3.62

8.18

1.2

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

198

629

1.60

8.16

1.3

1.2

14.6

17.6

0.23

108

(3013466) aPTT in Blood by Coagulation assay

119

2.48

8.10

1.1

36.4

37.0

0.26

(3034426) Prothrombin time (PT)

235

779

1.54

8.09

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

116

2.50

8.08

1.1

1.0

12.6

9.5

u/l

0.29

116

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

102

267

1.95

8.04

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.96

8.00

1.1

—

mmol/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

202

2.09

7.94

1.5

1.7

2.9

2.6

mg/l

0.15

145

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

202

2.09

7.94

1.5

1.7

3.8

4.5

mg/l

0.36

131

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

202

2.09

7.94

1.5

1.7

1.9

1.8

mg/l

0.06

149

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

202

2.09

7.94

1.5

1.7

2.8

3.2

mg/l

0.21

143

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

202

2.09

7.94

1.5

1.7

2.4

2.1

mg/l

0.17

153

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

202

2.09

7.94

1.5

1.7

0.9

2.4

mg/l

3.11

128

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

202

2.09

7.94

1.5

1.7

1.3

1.6

mg/l

0.17

128

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

202

2.09

7.94

1.5

1.7

0.8

1.1

mg/l

0.54

143

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

202

2.09

7.94

1.5

1.7

1.2

2.8

mg/l

2.46

139

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1170

4960

1.20

7.80

1.5

1.4

134.4

100.8

pmol/l

1.24

1139

4840

(3020393) Adenovirus Ag [Presence] in Stool

105

281

1.90

7.79

1.8

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.24

7.74

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

124

353

1.79

7.63

2.9

2.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.09

7.58

1.7

1.6

0.0

0.4

u/l

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

130

2.35

7.52

1.1

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

166

2.18

7.51

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

184

2.10

7.40

3.1

1.6

1.1

mg/l

0.54

121

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

109

301

1.84

7.39

1.3

22.9

25.5

0.40

248

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

133

391

1.73

7.37

1.3

1.2

—

(4281824)

497

1922

1.32

7.32

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

225

757

1.51

7.30

2.4

2.5

269.1

393.5

e6/l

0.69

138

393

(3006567) Chloride [Moles/time] in 24 hour Urine

6.94

7.21

1.4

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.98

7.20

1.2

1.3

3799.3

2747.8

ng/l

0.40

(3027570) Oxalate [Moles/time] in 24 hour Urine

120

2.38

7.20

1.4

328.9

311.4

umol/24h

0.27

120

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.65

7.18

1.1

1.0

101.2

98.6

nmol/24h

0.05

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

8270

39625

1.07

6.99

2.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

135

2.26

6.96

1.3

1.1

2.1

ml/s/173m2

1.03

(44786800) Granulocytes/100 leukocytes in Body fluid

145

2.21

6.94

1.3

28.8

24.4

0.37

117

(3014891) Appearance of Pleural fluid

155

2.17

6.94

1.7

1.5

—

(3002619) Bacteria identified in Specimen by Culture

130

388

1.71

6.87

1.2

—

(4212803)

2.49

6.83

1.1

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1969

11361

0.88

6.80

2.0

1.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

135

409

1.68

6.76

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

773

4809

0.82

6.75

1.6

—

(3011544) Albumin [Mass/volume] in Pleural fluid

102

2.45

6.71

1.1

16.5

18.3

g/l

0.62

(3028679) Herpes simplex virus Ab [Presence] in Serum

383

1448

1.35

6.63

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

238

831

1.46

6.51

1.1

261.3

424.8

ng/l

0.45

173

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

216

1.93

6.45

3.6

3.0

39.3

44.3

umol/l

1.01

186

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1982

8903

1.14

6.43

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

277

998

1.41

6.42

1.0

284.1

335.3

ng/l

2.14

200

732

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

147

2.15

6.41

1.2

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

147

2.15

6.41

1.2

1.0

2.0

1.6

umol/24h

0.93

147

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

278

1003

1.41

6.39

1.0

757.5

726.1

ng/l

0.53

199

707

(3010144) Erythrocytes [#/volume] in Synovial fluid

428

1655

1.32

6.38

1.4

121046.6

100381.1

e6/l

0.23

302

1140

(3034891) Synovial lining cells/100 cells in Synovial fluid

247

873

1.44

6.35

1.5

3.7

4.3

0.25

199

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

260

929

1.43

6.31

1.3

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

193

1.98

6.30

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

278

1006

1.41

6.30

1.0

37.6

45.3

ng/l

1.84

195

723

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

158

509

1.58

6.27

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.49

6.27

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

230

1.88

6.20

1.2

1.1

—

(3019174) dRVVT (LA screen)

198

1.95

6.18

1.3

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

119

359

1.69

6.10

1.2

41.5

64.8

mg/l

0.20

265

(3018851) Theophylline [Moles/volume] in Serum or Plasma

104

2.35

6.09

1.6

1.8

38.7

45.4

umol/l

1.01

104

(3024869) Neuronal Ab [Presence] in Serum

104

302

1.75

6.09

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

235

830

1.44

6.09

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

137

2.16

6.07

1.3

1.1

21.3

22.9

u/l

0.16

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

165

2.04

6.01

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.46

6.00

1.3

1.2

135.9

102.2

ug/l

0.59

(44813793)

449

1766

1.30

5.95

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

256

1.81

5.92

2.4

1.8

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.73

5.91

1.7

1.4

2.2

1.8

mmol/24h

0.86

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

935

3996

1.19

5.84

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

439

1.60

5.81

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

158

2.03

5.71

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

114

2.23

5.70

3.9

5.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

124

2.18

5.70

1.3

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

114

347

1.67

5.69

1.2

1.3

371.6

311.3

ug/l

0.09

182

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

871

3711

1.20

5.65

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

101

298

1.73

5.64

1.3

1.4

71.5

190.2

titre

0.80

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

5.09

5.62

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2704

12474

1.11

5.60

1.5

1.4

—

(3017509) Phencyclidine [Presence] in Urine

116

358

1.65

5.52

1.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

185

1.93

5.52

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

880

3762

1.19

5.51

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

9039

43767

1.06

5.44

2.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

261

962

1.38

5.39

2.4

2.2

21.2

276.5

ug/l

1.60

247

917

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.08

5.38

1.3

1.1

287.5

239.5

nmol/l

0.34

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1576

7073

1.14

5.26

1.5

1.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.37

5.21

1.2

1.1

78.4

121.6

u/l

0.24

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

197

1.86

5.16

1.0

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

141

2.02

5.07

1.4

69.9

69.8

0.01

113

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

184

1.88

5.05

1.1

1.3

45.0

47.2

mg/l

0.18

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

206

1.83

5.04

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

199

1.84

5.02

2.9

3.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

101

2.22

4.99

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

656

2769

1.21

4.78

1.7

1.6

8.2

7.2

mmol/l

10.23

411

1604

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

271

1.69

4.75

1.4

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

252

1.72

4.74

1.0

—

(3032641) Amino acids panel - Urine

3.11

4.66

1.3

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

300

1.65

4.65

1.1

—

(3006462) Nitrate [Presence] in Urine

255

962

1.35

4.63

3.0

2.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

154

1.92

4.58

2.3

2.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.20

4.58

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

298

1.64

4.55

4.0

7.1

68.8

72.8

0.67

226

(4211845)

277

1062

1.33

4.53

2.9

2.4

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

3.03

4.48

3.2

2.2

1035.8

2213.7

umol/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1453

8299

0.89

4.41

1.5

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.39

4.32

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.39

4.32

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.39

4.32

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.39

4.32

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.39

4.32

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.39

4.32

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

245

1.68

4.25

1.5

—

(3005033) Fetal Nuchal fold Thickness US

1453

8273

0.89

4.20

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

107

349

1.56

4.19

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1491

8465

0.89

4.10

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

213

1.72

4.10

1.7

1.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

232

882

1.34

4.07

1.1

1.0

9.5

12.3

u/ml

0.32

114

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

205

766

1.36

4.02

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

215

1.70

3.98

1.3

1.2

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

2.22

3.93

1.3

1.1

1.2

u/field

0.02

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

397

1628

1.24

3.91

1.1

6.7

8.1

iu/ml

0.57

453

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

930

4120

1.15

3.88

1.2

1.1

12.0

11.9

au/ml

0.01

303

(3034092) Cytoplasmic Ig cells/100 cells in Blood

309

1.57

3.80

11.2

4.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

150

537

1.42

3.80

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7447

36220

1.05

3.78

2.8

0.7

0.8

ug/l

2.80

4683

21807

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

1.96

3.78

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.05

3.75

1.2

1.1

2.6

3.1

0.31

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3953

18879

1.07

3.71

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

218

1.66

3.59

3.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

120

1.91

3.59

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

306

1.55

3.57

1.7

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

105

356

1.50

3.53

1.1

1.2

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

8.14

3.51

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

182

684

1.35

3.50

3.2

3.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

937

4190

1.14

3.46

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

186

1.70

3.43

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.76

3.39

1.2

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.13

3.32

1.0

0.2

0.1

u/ml

0.22

(3013166) Neutrophils/100 leukocytes in Synovial fluid

144

526

1.39

3.32

1.4

1.3

51.5

52.7

0.13

118

460

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.07

3.30

2.3

1.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

132

476

1.41

3.27

1.3

37.6

41.2

g/l

1.66

262

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.09

3.26

3.0

2.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

293

1.53

3.25

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

263

1683

0.79

3.24

1.6

1.4

—

(3007463) Buprenorphine [Presence] in Urine

136

1.80

3.23

8.0

8.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

190

1.66

3.20

1.1

—

(36303858) Crystals [Presence] in Urine

3.24

3.19

1.1

—

(3048879) Bone marrow aspiration report

119

424

1.43

3.17

2.1

—

(40768795) Lymph node Pathology biopsy report

470

2010

1.19

3.14

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

149

1.74

3.12

1.3

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

353

1472

1.22

3.08

1.4

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

187

722

1.32

3.07

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1230

5639

1.11

3.06

1.1

6.2

u/ml

0.02

641

3083

(4015189)

117

419

1.42

3.04

2.6

2.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1174

5370

1.11

3.04

1.1

1.5

1.2

u/ml

0.53

518

2436

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

209

1.61

3.03

2.1

1.8

—

(3050794) Legionella sp Ab [Presence] in Serum

170

1.68

3.01

1.1

1.2

—

(3006969) Lambda light chains [Mass/volume] in Urine

3.10

3.00

1.1

1.0

0.0

g/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

107

379

1.44

2.96

2.5

2.6

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.62

2.95

1.5

1.3

139.7

132.4

nmol/l

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

2.70

2.95

1.1

1.3

131.5

206.1

nmol/l

0.79

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

100

350

1.45

2.95

1.2

1.1

0.0

0.4

u/ml

1.77

225

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.82

2.94

1.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

247

1.55

2.94

1.5

1.3

53.1

55.6

0.15

132

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.39

2.92

1.4

0.8

u/field

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

218

1405

0.79

2.91

1.4

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

347

1454

1.22

2.91

1.4

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

142

531

1.36

2.90

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

142

531

1.36

2.90

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

456

1961

1.18

2.89

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

115

1.81

2.88

1.0

1.1

12.4

15.8

iu/ml

0.20

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

142

532

1.36

2.87

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.00

2.86

1.5

1.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

197

1.60

2.83

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

251

1.52

2.76

1.1

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.32

2.76

1.0

0.0

u/ml

0.29

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1978

9324

1.08

2.74

1.5

1.6

—

(40765096) Chromosome analysis panel by Banding

137

516

1.35

2.70

1.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.95

2.69

1.1

1.0

36.7

36.0

0.38

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.95

2.69

1.1

1.0

20.5

21.7

0.72

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.95

2.69

1.0

8.5

8.6

0.03

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.05

2.68

1.0

0.0

0.1

u/ml

—

(40768800) Prostate Pathology biopsy report

655

3795

0.88

2.67

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

249

1.51

2.67

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

102

720

0.72

2.66

1.8

1.9

—

(3014178) Parietal cell Ab [Units/volume] in Serum

5.94

2.66

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

152

584

1.33

2.64

1.1

7.4

6.4

mg/g

0.67

143

553

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

158

611

1.32

2.62

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

120

445

1.37

2.62

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

120

445

1.37

2.62

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

120

445

1.37

2.62

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

120

445

1.37

2.62

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.47

2.54

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.23

2.54

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

153

1010

0.77

2.53

2.7

3.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

104

379

1.40

2.52

2.0

1.7

4.7

3.7

ug/l

0.13

228

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

153

1009

0.77

2.52

5.4

6.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.63

2.51

1.1

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

4.52

2.50

2.4

3.7

—

(3033942) Copper [Moles/time] in 24 hour Urine

102

1.80

2.50

1.5

1.0

2.2

0.3

umol/24h

1.14

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

116

432

1.37

2.48

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.07

2.46

1.0

1.2

0.1

g/l

0.57

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.85

2.43

8.7

5.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.18

2.43

1.5

1.3

—

(3028468) Fragments [Presence] in Blood by Light microscopy

5.09

2.42

1.0

2.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

307

1299

1.20

2.40

1.2

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

2.11

2.37

1.2

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

175

1.57

2.34

1.2

1.3

6.0

6.1

mmol/l

0.07

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1343

6279

1.09

2.33

1.1

1.7

1.9

u/ml

0.51

567

2700

(3013293) Extractable nuclear Ab [Presence] in Serum

317

1.41

2.31

1.8

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

273

1149

1.21

2.28

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

301

1.42

2.28

1.4

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

125

1.67

2.25

1.6

1.4

30.3

38.3

0.54

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.20

2.25

4.5

5.9

0.3

0.2

mmol/l

0.79

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

6644

32632

1.04

2.25

1.5

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.81

2.24

1.1

1.0

—

(3007916) DNA double strand Ab [Titer] in Serum

239

1.47

2.23

1.4

152.0

171.9

titre

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

206

1.51

2.22

2.8

3.0

14.3

5.8

1.29

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

146

1.60

2.19

1.1

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

5.09

2.13

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

104

1.71

2.12

2.1

2.3

—

(3018291) Platelet Ab [Presence] in Serum

2.39

2.12

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

949

4389

1.10

2.12

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

230

1.46

2.09

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.90

2.08

1.0

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.95

2.06

1.2

1.3

1.1

1.4

u/field

0.84

(3027874) Urate [Moles/volume] in Urine

2.02

2.05

1.1

1.0

2.1

12.1

mmol/l

0.48

(3036048) Francisella tularensis Ab [Titer] in Serum

134

528

1.29

2.03

1.2

435.0

557.5

titre

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.80

2.02

8.8

9.6

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.04

2.01

1.5

1.4

196.7

292.7

nmol/l

0.54

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

120

467

1.31

2.00

1.3

39.2

41.3

0.22

336

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

138

1.59

1.98

1.3

1.4

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

1.81

1.97

1.0

1.1

0.2

g/l

0.05

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

508

2280

1.13

1.96

1.5

1.3

109.5

74.5

pmol/l

0.40

222

543

(3020650) Glucose [Presence] in Urine

158

640

1.26

1.94

1.4

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

131

1.59

1.93

1.3

1.2

17.7

18.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.54

1.92

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.00

1.92

1.1

u/field

0.01

(3024316) Viscosity of Plasma

1.71

1.91

1.3

2.1

1.5

1.7

mpas

1.43

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

211

884

1.22

1.91

1.1

—

(3009992) Blasts/100 cells in Bone marrow

3.13

1.84

2.1

1.3

9.1

28.8

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.86

1.84

1.1

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

250

1.40

1.83

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

138

1.55

1.79

1.5

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

122

1.59

1.78

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.92

1.75

1.1

1.0

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

2.09

1.73

1.4

1.2

62.6

87.0

0.52

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

5175

25445

1.04

1.71

2.0

2.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.28

1.71

1.3

1.1

134.4

136.1

mmol/24h

0.04

(3025130) Human papilloma virus identified in Specimen

716

4001

0.91

1.68

1.8

1.7

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

199

1.43

1.67

1.0

0.2

2.4

u/ml

1.92

150

(1617658) Protocol used for examination of sentinel lymph nodes

263

1560

0.86

1.64

1.1

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

4.24

1.64

1.0

1.2

—

(3019529) Immunofixation for Cerebral spinal fluid

4.24

1.64

1.0

1.2

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

4.24

1.64

1.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

2.54

1.62

2.6

2.4

—

(3038702) Sodium [Moles/volume] in Capillary blood

3.39

1.59

6.2

2.3

137.3

140.7

mmol/l

—

(3011325) HIV 1+2 Ab [Presence] in Serum

110

1.57

1.1

1.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

768

4260

0.92

1.56

3.3

2.0

13.2

13.1

2.90

758

4205

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

241

1.37

1.55

1.0

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.86

1.54

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

207

1.40

1.54

1.0

0.1

1.1

u/ml

0.75

(3042951) Complement C1q Ab [Units/volume] in Serum

107

1.57

1.52

1.1

1.3

13.3

18.9

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

344

1.30

1.50

1.0

1.1

0.2

0.9

u/ml

1.24

178

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

322

1.31

1.49

1.0

0.0

0.2

u/ml

3.61

197

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.72

1.49

1.0

0.3

0.9

u/ml

0.90

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

314

1.31

1.47

1.0

—

(40763590) HLA-DQ beta [Type]

1.64

1.47

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.64

1.47

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

3.63

1.46

1.2

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

3.63

1.46

1.2

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.18

1.45

1.5

1.4

—

(3036180) Methadone [Presence] in Urine

1.75

1.44

2.4

3.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

269

1186

1.15

1.44

7.0

5.6

1021.3

3803.8

u/ml

0.47

224

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.72

1.43

1.1

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

347

1.29

1.42

1.0

1.1

1.2

3.4

u/ml

0.51

180

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.67

1.42

1.0

0.1

0.2

u/ml

0.52

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.62

1.41

1.1

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1035

4908

1.07

1.40

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

181

1.41

1.40

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

114

1.52

1.38

1.7

1.5

16.6

11.3

0.46

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

173

1.41

1.38

1.1

1.0

0.1

0.6

u/ml

1.90

161

(3036312) Salmon IgE Ab [Units/volume] in Serum

173

1.41

1.38

1.1

3.2

1.7

u/ml

0.54

126

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.18

1.31

1.0

1.1

18.8

20.1

umol/l

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.63

1.30

1.3

1.4

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

379

1.26

1.30

1.2

1.1

20.2

20.0

mmol/l

0.16

345

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.15

1.30

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

307

1.29

1.30

4.3

3.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

141

1.44

1.30

1.0

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

151

641

1.20

1.30

1.1

0.9

2.2

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1030

4906

1.07

1.26

1.1

—

(40760410) HLA-B [Type] by High resolution

1.58

1.25

1.0

—

(40760409) HLA-A [Type] by High resolution

1.58

1.25

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

360

1.26

1.22

1.0

1.1

0.6

5.8

u/ml

2.65

286

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.53

1.21

2.5

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

205

902

1.16

1.18

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.14

1.15

1.1

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

341

1.25

1.14

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

185

1.35

1.12

1.1

1.0

3.5

3.0

u/ml

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

133

1.42

1.12

1.5

1.6

—

(3013862) HLA-DP [Type]

1.52

1.11

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

142

1.40

1.11

1.1

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

583

3212

0.92

1.10

3.7

3.6

28.4

36.8

u/ml

1.27

562

3099

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

169

998

0.86

1.10

1.1

—

(3022475) Manganese [Moles/volume] in Blood

138

1.40

1.09

1.3

—

(3001729) Color of Synovial fluid

134

1.41

1.08

1.7

1.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

139

1.39

1.06

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

101

1.46

1.04

2.3

1.8

0.7

0.6

umol/l

0.76

(21494567) Legionella sp IgM Ab [Presence] in Serum

149

1.37

1.01

1.0

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

315

1.24

1.01

1.0

1.1

0.1

0.5

u/ml

2.35

168

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.45

0.99

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

141

0.65

0.99

1.1

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.46

0.98

1.3

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.58

0.98

1.0

—

(40762814) Titanium [Mass/volume] in Blood

262

1.26

0.97

2.3

4.0

3.8

ug/l

0.12

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

500

2753

0.92

0.97

1.5

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

363

1.22

0.96

1.0

1.1

1.3

2.7

u/ml

0.82

283

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.35

0.96

1.2

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

1.44

0.95

1.6

1.2

0.6

1.7

1.42

(3041672) Baker's yeast Ab [Presence] in Serum

151

1.35

0.95

1.0

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.87

0.95

1.3

1.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

134

1.37

0.93

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

2.04

0.93

1.0

1.1

—

(3013762) Body weight Measured

1.46

0.92

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1908

10088

0.96

0.92

1.4

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

117

1.39

0.92

1.2

1.0

3.6

3.2

u/l

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1907

10081

0.96

0.91

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

113

1.40

0.91

1.8

1.6

0.4

0.5

0.41

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

380

1.21

0.90

1.3

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

1.49

0.90

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

213

963

1.13

0.89

2.1

2.6

2.4

ug/l

0.22

176

825

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1900

10031

0.96

0.87

1.4

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

2.04

0.85

3.2

6.3

—

(3016031) Almond IgE Ab [Units/volume] in Serum

240

1.25

0.85

1.1

0.4

1.1

u/ml

1.68

150

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1907

10057

0.96

0.83

1.4

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.82

0.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.45

0.81

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

179

808

1.13

0.80

1.8

1.7

171.8

129.0

au/ml

0.40

104

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

405

1.18

0.79

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

203

925

1.12

0.78

1.2

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

216

988

1.11

0.78

2.0

4.0

3.6

ug/l

0.18

184

890

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

337

1.19

0.75

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.65

0.74

2.3

2.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.48

0.72

1.1

1.0

0.0

0.3

u/ml

0.80

(3020356) Listeria sp identified in Specimen by Organism specific culture

205

1.24

0.70

1.1

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

233

1.22

0.69

2.3

2.0

0.6

0.5

u/field

0.29

233

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

4109

20476

1.02

0.67

1.9

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.47

0.67

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.48

0.66

4.1

5.8

13.8

5.0

mg/l

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.82

0.65

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

2050

10737

0.97

0.65

1.5

—

(3015183) Erythrocyte sedimentation rate

306

1440

1.08

0.65

1.2

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.64

0.0

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

204

1.22

0.62

1.0

1.1

27.0

26.6

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

204

1.22

0.62

1.0

1.1

31.0

28.4

u/ml

0.09

(3034614) HLA Ag [Interpretation]

1.45

0.61

1.3

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

360

1.16

0.60

1.6

1.5

—

(4038314)

281

1.18

0.58

1.3

1.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.70

0.57

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.55

0.56

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

331

0.85

0.56

2.1

2.7

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.45

0.55

1.0

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

200

935

1.09

0.53

1.1

3.0

18.1

u/ml

0.92

109

592

(3003157) Bacteria [#/volume] in Mother's milk

1.37

0.52

4.8

7.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

245

0.83

0.51

1.3

1.4

2.7

7.4

u/ml

0.79

199

(3027974) Hepatitis B virus e Ag [Presence] in Serum

140

1.24

0.50

1.5

1.6

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.34

0.50

1.1

1.0

0.1

u/ml

0.26

(3022670) pH of Venous cord blood

108

1.27

0.50

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

218

1030

1.08

0.47

2.8

3.0

—

(3009677) Dengue virus Ab [Presence] in Serum

131

0.78

0.46

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

137

636

1.10

0.45

1.1

1.2

2.7

8.1

u/ml

2.25

460

(3007700) Barley IgE Ab [Units/volume] in Serum

147

1.21

0.45

1.1

1.0

0.2

10.6

u/ml

0.53

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

216

1023

1.07

0.45

2.3

2.0

8.2

9.8

mg/l

3.57

176

817

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.36

0.44

1.1

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

8580

43220

1.01

0.44

1.5

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.43

0.0

1.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.39

0.40

1.0

1.1

—

(4133840)

160

755

1.08

0.39

1.2

—

(40768793) Breast Pathology biopsy report

914

4792

0.97

0.39

1.3

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.40

0.37

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

236

1.14

0.37

1.5

1.3

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.27

0.36

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

161

1.17

0.35

1.1

1.0

0.2

12.2

u/ml

0.52

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.39

0.35

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

295

1427

1.05

0.35

1.9

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

200

1.14

0.33

1.1

1.0

11.7

22.6

u/ml

1.84

161

(3015350) Toxocara sp Ab [Presence] in Serum

1.42

0.33

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.38

0.32

1.1

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.33

0.31

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

925

4821

0.98

0.29

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.31

0.29

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.27

0.28

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.24

0.28

1.3

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

175

843

1.06

0.27

2.7

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1101

5489

1.02

0.26

1.1

2.2

2.7

u/ml

0.58

277

1462

(46235168) Fasting glucose [Moles/volume] in Blood

297

1.10

0.26

1.4

1.1

8.8

5.6

mmol/l

3.01

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

142

0.86

0.25

1.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

1.22

0.24

1.1

1.0

14.0

11.3

u/ml

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.73

0.23

1.3

—

(3006598) pH of Arterial cord blood

327

0.92

0.23

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.22

0.0

1.2

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

326

0.92

0.22

1.0

7.5

7.2

kpa

0.80

284

(40760512) CD34 cells/100 cells in Bone marrow

1.27

0.21

1.7

1.5

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.16

0.21

1.0

0.9

0.5

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

406

2009

1.03

0.20

1.1

2.8

3.3

u/ml

0.10

133

626

(3004959) Base excess in Arterial cord blood by calculation

324

0.93

0.20

1.0

-1.2

-1.9

mmol/l

0.27

(3003577) Lead [Moles/volume] in Blood

223

0.91

0.19

1.4

0.2

umol/l

0.61

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.87

0.15

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

319

0.94

0.14

1.0

3.0

3.4

kpa

1.79

276

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.21

0.14

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1114

5599

1.01

0.14

1.8

1.7

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

114

0.89

0.14

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

264

1.06

0.12

1.0

0.4

1.4

u/ml

1.35

174

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

751

3771

1.01

0.12

1.1

1.0

0.8

0.4

u/ml

0.56

168

839

(40758358) Immune stain study

0.89

0.11

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

852

4382

0.99

0.11

1.1

6.7

5.6

u/ml

0.51

354

1915

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1753

8857

1.01

0.10

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

215

1117

0.98

0.09

1.8

2.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

377

1.04

0.09

1.0

9.8

8.6

mu/l

0.50

322

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

118

1.08

0.09

4.0

5.6

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.77

0.08

2.0

2.4

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.83

0.07

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

395

1986

1.01

0.07

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

113

589

0.98

0.07

1.2

1.3

10.0

8.7

u/ml

0.05

131

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

517

0.97

0.07

1.1

—

(40758292) HTLV I+II Ab panel - Serum

450

0.97

0.07

1.4

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

238

0.96

0.06

1.1

4.2

10.6

u/ml

3.15

161

(3014599) Egg white IgE Ab [Units/volume] in Serum

394

1985

1.01

0.06

1.1

2.0

5.0

u/ml

1.19

109

552

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

316

1.03

0.05

1.6

1.7

1.8

1.7

mg/l

0.32

266

(3014133) Dog dander IgE Ab [Units/volume] in Serum

917

4693

0.99

0.05

1.1

4.2

5.1

u/ml

0.65

373

1929

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

225

1130

1.01

0.05

2.5

2.8

161.9

131.1

au/ml

0.41

149

(3036071) Salmonella sp Ab [Titer] in Serum

170

852

1.02

0.05

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

106

1.06

0.04

1.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

101

1.06

0.04

1.0

0.2

0.4

u/ml

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.92

0.04

1.0

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

246

1242

1.01

0.03

3.0

3.4

7.4

8.4

mg/l

1.61

198

1007

(3020618) Glucose [Moles/volume] in Synovial fluid

0.93

0.02

1.0

1.1

6.3

3.9

mmol/l

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

358

1816

1.00

0.01

1.0

1.1

0.6

0.9

u/ml

0.43

276

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.05

0.00

1.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.03

0.00

1.1

1.0

0.2

1.4

u/ml

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

108

550

1.00

0.00

1.2

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

109

1.03

0.00

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

332

1692

1.00

0.00

1.3

1.2

1.4

1.5

g/l

0.67

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

216

1.01

0.00

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

123

0.99

0.00

1.0

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

0.98

0.00

1.6

1.7

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.02

0.00

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.02

0.00

1.3

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.02

0.00

1.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.91

0.00

1.3

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.02

0.00

1.2

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.90

0.00

1.2

1.0

2166.7

1740.9

titre

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_ENDONUTRMET – Endocrine, nutritional and metabolic diseases

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Endocrine, nutritional and metabolic diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Endocrine, nutritional and metabolic diseases (E4_ENDONUTRMET)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints